Abstract
Norepinephrine (NE) is synthesized in the Locus Coeruleus (LC) of the brainstem, from where it is released by axonal varicosities throughout the brain via volume transmission. A wealth of data from clinics and from animal models indicates that this catecholamine coordinates the activity of the central nervous system (CNS) and of the whole organism by modulating cell function in a vast number of brain areas in a coordinated manner. The ubiquity of NE receptors, the daunting number of cerebral areas regulated by the catecholamine, as well as the variety of cellular effects and of their timescales have contributed so far to defeat the attempts to integrate central adrenergic function into a unitary and coherent framework. Since three main families of NE receptors are represented—in order of decreasing affinity for the catecholamine—by: α2 adrenoceptors (α2Rs, high affinity), α1 adrenoceptors (α1Rs, intermediate affinity), and β adrenoceptors (βRs, low affinity), on a pharmacological basis, and on the ground of recent studies on cellular and systemic central noradrenergic effects, we propose that an increase in LC tonic activity promotes the emergence of four global states covering the whole spectrum of brain activation: (1) sleep: virtual absence of NE, (2) quiet wake: activation of α2Rs, (3) active wake/physiological stress: activation of α2- and α1-Rs, (4) distress: activation of α2-, α1-, and β-Rs. We postulate that excess intensity and/or duration of states (3) and (4) may lead to maladaptive plasticity, causing—in turn—a variety of neuropsychiatric illnesses including depression, schizophrenic psychoses, anxiety disorders, and attention deficit. The interplay between tonic and phasic LC activity identified in the LC in relationship with behavioral response is of critical importance in defining the short- and long-term biological mechanisms associated with the basic states postulated for the CNS. While the model has the potential to explain a large number of experimental and clinical findings, a major challenge will be to adapt this hypothesis to integrate the role of other neurotransmitters released during stress in a centralized fashion, like serotonin, acetylcholine, and histamine, as well as those released in a non-centralized fashion, like purines and cytokines.
Keywords: norepinephrine, adrenoceptors, stress, fight-or-flight response, ADHD, depression, psychosis, anxiety
Berserk
“Early 19th century (originally as a noun denoting a wild Norse warrior who fought with frenzy): from Old Norse berserkr (noun), probably from birn-, bjorn (bear) + serkr “coat,” but also possibly from berr “bare” (i.e., without armor).” Oxford Dictionary.
“His (Odin's) men rushed forwards without armor, were as mad as dogs or wolves, bit their shields, and were strong as bears or wild oxen, and killed people at a blow, but neither fire nor iron told upon them. This was called Berserkergang.” Ynglinga saga and Laing Samuel (1889). The Heimskringla or the Sagas of the Norse Kings. London: John. C. Nimo. p. 276.
“If a soldier survives the berserk state, it imparts emotional deadness and vulnerability to explosive rage to his psychology and permanent hyperarousal to his physiology—hallmarks of post-traumatic stress disorder in combat veterans. My clinical experience with Vietnam combat veterans prompts me to place the berserk state at the heart of their most severe psychological and psycho-physiological injuries.” Shay Jonathan (1994). Achilles in Vietnam. New York: Scribner. p. 98. ISBN 0-689-12182-2.
Introduction
Neurotransmitters controlling the spatio-temporal brain activation patterns
Evolution has shaped the mammalian brain during millions of years, endowing it with redundant and inter-related neurotransmitter networks to manage and administer stress. The characteristics of the “berserk,” the ultimate warrior—superhuman physical strength, insensitivity to pain, lack of concern for the consequences of his actions—are possibly the display of an extreme state, an upper limit of human physical and mental condition at the core of norepinephrine (NE)-induced states.
Although a variety of hormones may turn on neuronal circuits for the execution of energetically demanding behavioral tasks, only a fistful of neurotransmitters have the capability to actually regulate the global state of activation of the whole brain, managing effectively and parsimoniously the necessarily limited energy/power capability of the brain and of the whole organism. The NE-releasing Locus Ceruleus (LC) is anatomically and functionally intertwined with the brain area which is arguably the major recipient of stress-related information: the paraventricular nucleus of the hypothalamus (PVN, Figure 1). Other hypothalamic nuclei also impinge upon the LC. Among them the hypocretin-expressing nuclei in the lateral hypothalamus (Henny et al., 2010; Carter et al., 2012). The hypothalamus-LC axis controls input and output information from and to the autonomic system through the brainstem, to and from the neuroendocrine system through the pituitary gland and numerous gland-to-brain biochemical feedback loops, as well as all the rest of the central nervous system (CNS), through brain and spinal cord volume transmission (Figure 1).
Further hints of the biological importance and pervasiveness of central adrenergic function come from the analgesic properties of NE and its agonists (Simpson and Lin, 2007), by its important role in the control of body temperature, like during inflammatory response (Bencsics et al., 1995; Ordway et al., 2007; Osaka, 2009), as well as from the observation that other relevant input to the LC originate from nuclei coordinating vital functions like sex/reproduction (Nucleus Paragigantocellularis), respiration (Parabrachial and Solitary Tract Nuclei), and vestibular balance control (Simpson and Lin, 2007).
The control of the above functions is likely retained in the evolution from lower to higher mammals (Tohyama et al., 1974), but the increase in brain size and complexity associated with its disproportionate anatomical development makes the mammalian CNS particularly vulnerable to sudden surges in energy consumption caused by stressful situations. This latter evolutionary purpose might have further strengthened the importance of LC as master energy hub (Berridge and Waterhouse, 2003; O'Donnell et al., 2012), enhancing—particularly in humans—its role in the etiology of stress-related conditions.
Functional and anatomical peculiarity of the LC/NE system
Many hormones have a potential for global control of energy expenditure and activity regulation. Among them—for instance—the corticosteroid system is well placed for exerting a global and sophisticated biochemical regulation of energy demand and distribution (De Kloet, 2004), but lacks the property of anatomical and functional contiguity that the LC possesses. For similar reasons, the cytokine network, which also has the potential to control the brain (and bodily) global energy distribution (Guijarro et al., 2006), also does not seem to qualify as “central energy master.”
Central cholinergic fibers made up a highly divergent and almost ubiquitous release system (McKinney and Jacksonville, 2005; Smythies, 2005a). However, the existence of a large number of nuclei and brain areas that independently control the release of acetylcholine (Ach; Nucleus Basalis of Meynert, medial septum, latero-dorsal tegmentum, etc.), each toward or within their respective anatomical targets suggests that the cholinergic system hardly exerts a genuinely centralized control of energy expenditure.
The central histaminergic system stemming from the tuberomammillary nucleus of the hypothalamus appears to play a powerful and genuinely centralized role in triggering an emergency and alert maintenance response (Wada et al., 1991; Sakata et al., 1997; Shan et al., 2015). To our present knowledge, though, the histaminergic system does not appear to display a repertoire of cellular and synaptic actions paralleling the complexity and flexibility of the LC/adrenergic system, which is perhaps rivaled in its pervasiveness and variety of effects only by the Raphe/5HT system (Heisler et al., 2003; Zhou et al., 2005). In this respect, only serotonergic projections from the Raphe nucleus and the cholinergic fibers from the basal forebrain (Nucleus Basalis of Meynert) reach the extent and density of LC adrenergic projections throughout the CNS (Smythies, 2005b). The importance of the serotoninergic system in the coordination of the stress response has been reviewed elsewhere (Waselus et al., 2011).
While we highlight the importance of developing a comprehensive theory integrating the roles of the many neurotransmitters involved in the stress response, we will henceforth limit our discussion on the role of NE. In the following sections we will discuss experimental evidence relating central NE function to activities related to stress (stress perception, elaboration, and execution of a stress-ridding plan, as well as storage—or deletion—of related memories), and will make an attempt to integrate previous literature into a qualitative model in which increasing levels of NE co-ordinate the activity of different brain areas, inducing global brain states with increasing energy consumption and stress levels. We will only briefly mention the effects of NE on long-term processes, which we have recently reviewed elsewhere (Salgado et al., 2016).
It is worthwhile emphasizing the genuinely global nature of NE, differing from its chemical precursor dopamine, whose cortical projecting axons target more selectively the prefrontal cortex (Robbins and Arnsten, 2009). For the sake of clarity, we would like to highlight that stress activates two distinct pools of NE: a central one and a peripheral one, the latter associated with sympathetic nervous system activation. While the interaction between the two pools is essential to the understanding of the systemic effects of stress, only the former will be considered in the present discussion.
Stress, HPA axis, and LC activation
For the purpose of this discussion, we will broadly define stress as any situation in which an organism increases its energy consumption beyond an expected or biologically bearable range (which greatly varies even among individuals of the same species), and as stressor its objective or perceived source. We will get back to this definition of stress in Section LC-CNS Interactions. In the presence of most types of stressors the brain carries out the following (conscious or subconscious) functions: (1) evaluation of the stressor characteristics (short- or long-term intensity, duration, and consequences), (2) elaboration of a strategy to eliminate the stress(or), (3) execution of such plan, and (4) long-term storage (or in some case erasing) of stressor-related memories. Among these memories are the inner representations of the stress as a measure of potential danger, as well as the representation of one or more actual stress exit strategies, and their perceived effectiveness (or lack thereof).
In the historical context of the studies of the stress response, a critical element of adrenergic effects had been recognized early in the interaction between the hypothalamus-pituitary-adrenal gland (HPA) neuroendocrine axis and LC reviewed in Gold and Chrousos (2002) and Gold (2015). In fact, NE-releasing neurons of the LC are important targets of corticotropin-releasing hormone (CRH)-producing hypothalamic neurons from the PVN (Nicolaides et al., 2015), as well as from other limbic areas including the amygdala (Ordway et al., 2007), whose activity in turn stimulates LC leading to NE release. The importance of the PVN-LC axis is underscored by the observation that the inactivation of glucocorticoid receptors in the LC induces depression-like symptoms in a mouse model (Chmielarz et al., 2013).
A critical feature of the well-studied HPA response to stress is the negative feedback between the production of glucocorticoids and the activation of the HPA axis, which occurs both at the level of CRH-producing neurons in the PVN of the hypothalamus as well as in pituitary ACTH-producing corticotrophs (Figure 2). An energetically meaningful consequence of the elevation of glucocorticoid levels is the parallel shut-down or at least decrease of the high-energy consuming immune adaptive system, which in turn may increase the chance of infection and cancer in chronically stressed individuals (Reiche et al., 2004).
Importantly—unlike the glucocorticoid negative-feedback on HPA axis—the activation of the PVN/CRH/NE/LC branch of the stress response not only does not produce a negative feedback (Gold, 2015), but produces a positive feedback which opposes and jeopardizes the closure of the HPA loop associated with glucocorticoids (Figure 2). The presence of a feedforward loop between CRH-producing areas of the cortex and of the hypothalamus and the LC is a risk factor in the induction of maladaptive plasticity of the stress system, which greatly enhances its vulnerability to intense and/or chronic challenge. Systemic inflammation can be considered as the opposite phenomenon, whereby a combined action of pro-inflammatory cytokines induces a temporary state of physical apathy and inaction (Haroon et al., 2012; Miller et al., 2013). A consequence of such “sick response” is to spare systemic energy and promote a prompt recovery of the organism affected by a viral or bacterial infection.
Decade-long seminal work from the group of Aston-Jones and Waterhouse provides a solid ground for assessing the basic functions and activity dynamics of the LC (Rajkowski et al., 1994; Aston-Jones et al., 1998; Usher et al., 1999; Aston-Jones and Cohen, 2005; Aston-Jones and Waterhouse, 2016). Using mostly in vivo electrophysiological recordings from both primate and rodent models, this body of work has shown that LC displays virtually no activity during the sleep phase, whereas during the wake state it displays two emergent firing patterns: a tonic one, associated with the arousal level of the animal, and a phasic one, related with decision making and attention. Importantly, the extent of LC phasic firing appears to follow an inverse-U shape function with respect to the levels of tonic LC firing. In fact, while low levels of tonic firing—as during low arousal level—are insufficient to elicit a consistent behavioral response, intermediate tonic levels yield optimal phasic firing, whereas high levels of tonic firing—associated with high arousal and limbic activation—yield low phasic response as LC units firing activity gets closer to saturation. The eventual overall effect of NE depends on the spatio-temporal pattern of its volume release (Fuxe et al., 2010), on the nature of the cellular and synaptic targets affected, and on the type of receptor activated (summarized in Figure 3).
Molecular, cellular, and synaptic effects of NE
NE is released in the brain by axonal varicosities via volume transmission (Grzanna, 1980; Jones and Yang, 1985; Agnati et al., 1995). NE receptors have been first studied in the periphery and subsequently identified throughout the whole CNS, with different densities and regional specializations as reviewed earlier (Ramos and Arnsten, 2007). In terms of molecular effects, they can be categorized into three main groups, in descending order of affinity: α2Rs, (≈50 nM), α1Rs (≈300 nM), and βRs (≈0.7–0.8 μM) reviewed in Ramos and Arnsten (2007). Both α2- and β-Rs are known to activate guanosine-dependent (G–)protein receptors, each affecting adenylyl cyclase in opposite directions, namely by decreasing (α2Rs) or increasing (βRs) the intracellular concentrations of cyclic adenosine monophosphate (cAMP). In contrast, α1Rs activate phospholipase C (PLC), thus triggering the synthesis of intracellular diacylglycerol and activation of protein kinase C as well as of inositol phosphate, which in turn releases Ca2+ from intracellular stores (Ramos and Arnsten, 2007).
The existence of widespread families of high-affinity neurotransmitter receptors (NE α2Rs, M2 muscarinic, D2 dopaminergic) whose activation decreases adenylyl cyclase activity (Gi) suggests that basal (tonic) cytosolic levels of cAMP are not zero, and that they concur to the regular maintenance cellular processes active during cell rest. As a corollary, we hypothesize that the inactivity of the CNS noradrenergic system—similar to that of the other monoaminergic and the cholinergic system—during sleep is associated with a non-zero level of cAMP (Figure 4), and a tonic level of cellular energy expenditure. Such ground-level of cellular metabolic activity is possibly necessary to carry out a number of functions including a temporary enhancement of immune function during the resting phase (Kamath et al., 2015) and memory consolidation (Wilson and McNaughton, 1994; Barnes and Wilson, 2014; Figure 3). A slight increase in the concentration of neurotransmitters activating a Gi (in the case of NE up to 100 nM) could be sufficient to shut down such sleep-associated maintenance cellular processes and re-direct cellular metabolic energy to the quiet-wake related activities. Only relatively higher NE concentrations (around or above 0.4 μM) would be able to solidly activate the PLC cascade and increase cAMP levels above its resting levels (Figure 3), increasing the cellular supply for more energetically demanding biological activities (Figure 4).
Cellular and synaptic adrenergic modulation (Salgado et al., 2016) suggests that the activation of the cortical branch of the LC/adrenergic system could simultaneously perform two tasks: (1) single neuron activation by modulation of intrinsic conductances, with consequent local mobilization of large amounts of metabolic energy, and (2) temporary shut down or depression of the activity of other cortical areas that are unnecessary or irrelevant to the resolution of a particular behavioral contingence. This end could be achieved by a combination of selective depression of excitatory and enhancement of inhibitory synaptic transmission (Waterhouse et al., 1991; Sessler et al., 1995; Salgado et al., 2016).
Heterogeneous mechanisms of adrenergic modulation in different cortical areas like sensory vs. prefrontal cortices (Salgado et al., 2011, 2012b; Roychowdhury et al., 2014) together with activity-dependent modulation may concur to a functional selective enhancement or depression of neuronal activity in specific areas (Hains and Arnsten, 2008; Arnsten et al., 2012; Edeline, 2012; Roychowdhury et al., 2014). In the following sections we will review experimental evidence of effects of the noradrenergic receptor families mentioned above, from clinics and animal models, in an attempt to condense the related information in an integrated view. In many cases it will be hard to guess how a particular cellular or synaptic phenomenon participates into a behavioral function. In the tables we will either report the author's interpretation of their experimental finding, or will formulate a plausible one, keeping in mind that the same cellular experimental data may play different roles in a systemic function.
α2Rs central modulation
α2Rs are present in many brain areas in both pre- and post-synaptic membranes, as well as in glia (Lee et al., 1998).
Alertness and anxiolytic effects
Based on pharmacological observations in clinics and in animal models, the activation of α2Rs is deemed necessary for optimal performance in working memory and other tasks carried out with a strong prefrontal cortex (PFC) component (Gamo and Arnsten, 2011; Arnsten and Jin, 2012, 2014). Along with promoting working memory—and possibly related to it—α2Rs also appear to contribute to a plethora of functions such as attention and impulse inhibition (Brennan and Arnsten, 2008; Robbins and Arnsten, 2009). The activation of α2Rs decreases the inhibitory synaptic drive onto the tuberomammillary nucleus of the hypothalamus, contributing to alertness (Nakamura et al., 2013). α2R activation in the medial septum and hippocampus increases theta rhythm (Kitchigina et al., 2003), presumably enhancing cognition. The increase in spontaneous inhibitory postsynaptic currents (sIPSCs) in the PVN following α2R agonist application (Chong et al., 2004), together with the α2R-induced decrease in glutamatergic drive onto the ventral tegmental area (VTA) may contribute at least part to α2Rs anxiolytic properties.
PFC activity modulation
Ample evidence exists that α2Rs directly modulate PFC activity (Kovács and Hernádi, 2003; Wang et al., 2010), reviewed in Arnsten and Li (2005). Most of this literature indicates a beneficial effect of α2R activation for working memory, although in some studies beneficial effects of α2R blockers have been described (Brown et al., 2012; Bari and Robbins, 2013). The α2R-induced block of N-methyl-D aspartate receptor (NMDAR)-mediated current (Liu et al., 2006), would corroborate a role in PFC learning for this receptor, but it could also represent a faster “clearance” of PFC reverberant circuits. Particularly remarkable is the evidence from multiple studies, of the beneficial effects of α2R-induced block of dendritic hyperpolarization-activated cyclic nucleotide (HCN) channels (Wang et al., 2011; Zhang Z. et al., 2013), whose age-related decline is considered an important cause of cognitive deterioration (Wang et al., 2011).
Motor and sensory activity
α2R activation does modulate motor activity (Villégier et al., 2003), although not always in the same direction (Cathala et al., 2002; Carey and Regehr, 2009). α2R activation appears to modulate cerebellar activity, necessary for fine timing and control of distal movement (Hirono and Obata, 2006; Di Mauro et al., 2013; Lippiello et al., 2015). Little evidence is reported of α2R modulation of sensory areas, mainly in auditory (Leão and Von Gersdorff, 2002; Salgado et al., 2011) and olfactory (Nai et al., 2009) areas.
Clinical and pre-clinical studies
Different—sometimes contradictory—evidence about the global effects elicited by α2R ligands may perhaps be explained as the result of two contrasting actions on excitatory (pro-convulsive) presynaptic α2Rs and inhibitory (anti-convulsive) postsynaptic α2Rs, as revealed by an epilepsy study (Szot et al., 2004). It is worth mentioning that the use of tricyclic medication, used as antidepressant, may induce α2R internalization (Cottingham et al., 2015), perhaps indicating that depression may be associated with or even caused by an increase in α2R expression, possibly elicited by a high NE tone associated with prolonged stress.
Overall, the activation of α2Rs by an increased but moderate NE tone (possibly ≤ 100 nM), appears to increase alertness, improve working memory, attention, PFC function in general, and enhance fine motor control and sensory processing, possibly acting on pre- and post-synaptic receptors carrying out opposite functions. Table 1 reports a series of α2R-mediated effects grouped per putative function.
Table 1.
Measured or putative function of α2R activation | Brain area | α2R-related physiological effect/finding | References |
---|---|---|---|
INCREASE IN AROUSAL AND GENERAL ACTIVITY | |||
Modulation of NE release | LC | α2R are present pre- and post-synaptically and in glia | Lee et al., 1998 |
Increase arousal | Tuberomammillary nucleus | α2R activation decreases GABAergic synaptic transmission | Nakamura et al., 2013 |
Increase arousal and cognitive functions | Medial septum and hippocampus | α2R activation increase theta rhythm frequency | Kitchigina et al., 2003 |
Reduced stress response | PVN hypothalamus | α2R activation increases sIPSC frequency | Chong et al., 2004 |
Decreases limbic axis activation | VTA | α2R act decrease glutamatergic drive onto VTA cells | Jiménez-Rivera et al., 2012 |
Emotional memory consolidation during sleep | Human amygdala and hippocampus | α2R activation facilitates consolidation of memories | Groch et al., 2011 |
PREFRONTAL CORTEX/WORKING MEMORY/EXECUTIVE FUNCTION | |||
Improve Executive function | Systemic, in rodent, and primates | α2R activation | Arnsten and Li, 2005 |
Promote working memory | dlPFC | α2R activation promotes persistent firing | Arnsten, 2011 |
Modulates error detection | mPFC | LC lesion increases mPFC firing | Wang et al., 2010 |
α2R activation decreases mPFC firing | |||
Promote working memory | PFC | α2 block decrease firing frequency (α2 activation increase firing frequency) | Kovács and Hernádi, 2003 |
Promote working memory | PFC | α2Rs block HCN channels | Wang et al., 2011 |
Promote working memory | PFC | α2Rs prolong persistent activity (up-states) through block of HCN channels | Zhang Z. et al., 2013 |
Modulate working memory | mPFC in vivo | α2R act decrease glutamatergic transmission fEPSP. Mixed effect on synaptic transmission on multi- unit population (could be due to effects on inhibitory transmission) | Ji et al., 2008 |
Improvement of working memory | PFC | α2R activation blocks HCN channels and increases excitability | Carr et al., 2007 |
Promotes temporal summation | |||
Working memory | systemic | Block of α2R improves sustained attention and response inhibition | Bari and Robbins, 2013 |
Modulation working memory | PFC | α2R activation decrease NMDA currents | Liu et al., 2006 |
Increase false alarm/lower threshold for event detection | systemic | α2R activation increases false alarm | Brown et al., 2012 |
MODULATION OF MOVEMENT CONTROL BY α2 ADRENOCEPTORS | |||
Increase in locomotor activity | Systemic/overall brain | α2R agonists increase locomotor activity | Villégier et al., 2003 |
Decrease dopamine release/motor drive | Substatia Nigra pars compacta | α2R agonists activate a cationic current increasing sIPSC frequency | Cathala et al., 2002 |
Decrease motor learning | cerebellum | α2R activation decreases associative plasticity | Carey and Regehr, 2009 |
Promote fine movement control | cerebellum | α2R activation reduces IPSC | Hirono and Obata, 2006 |
Modulate cerebellar input | Cerebellar Purkinje cells | α2R activation reduce EPSC | Lippiello et al., 2015 |
Movement control fine tuning | Cerebellum | α2R activation increases and decreases GABA in different subareas | Di Mauro et al., 2013 |
MODULATION OF SENSORY ACTIVITY BY α2Rs | |||
Promotes olfaction | Olfactory bulb | α2R activation increases olfactory discrimination | Nai et al., 2009 |
Modulation of auditory sensitivity | Calyx of held | α2Rs activation decreases glutamatergic signaling but increases firing frequency | Leão and Von Gersdorff, 2002 |
Decrease auditory sensitivity | Auditory cortex | α2Rs activation increases GABAergic signaling | Salgado et al., 2011 |
ROLE OF α2Rs BRAIN PATHOLOGY | |||
Pro- and anti-convulsant effect | systemic | α2A presynaptic autoreceptors are responsible for the proconvulsant effect of α2R agonists | Szot et al., 2004 |
α2 postsynaptic receptors are responsible for the anticonvulsant effect of α2R agonists | |||
Antidepressant effect | Systemic | Tricyclics induce β arrestin-mediated internalization of α2Rs | Cottingham et al., 2015 |
Antidepressant effect | mPFC | α2R activation reduces AMPAR currents | Yuen et al., 2014 |
Improve executive functions | mPFC | Cannabinoid receptors (which impair working memory) decrease α2R function | Cathel et al., 2014 |
Decrease distress in drug addiction (seeking) behavior | BNST | α2R activation decreases excitatory transmission | Egli et al., 2005 |
Intra-BNST α2R agonists inhibit drug seeking |
α1Rs central modulation
A somehow controversial picture emerges from the literature concerning the roles of α1Rs, reporting either facilitatory or detrimental effects of cognitive function following the activation of α1Rs, depending on the assay used. Remarkable information comes from studies of different subtypes of α1R in constitutively activated mutant (CAM) mice, reviewed elsewhere recently (Nalepa et al., 2013). These studies suggest complex—sometime opposite—interplay of the different subtypes of α1Rs. CAM mice overexpressing α1BRs display neurodegeneration and grand mal-like seizures, probably caused by an imbalance between excitatory and inhibitory synaptic currents. Behavioral assays on these animals suggest a role for α1BRs in memory consolidation and fear-driven exploratory behavior (Knauber and Müller, 2000). On the other hand, α1ARs CAMs live 10% longer than controls, and display improved memory and learning (Doze et al., 2011), opposite to α1BRs CAMs (Collette et al., 2014). Another subtype of α1Rs, the α1DR appears to be inversely related to motor control, as α1DR KO mice perform better in the rotarod test (Mishima et al., 2004).
General activation and emotion regulation
In general, α1Rs activation promotes wake and activity by directly affecting neurons (Schmeichel and Berridge, 2013; Igata et al., 2014), and possibly also by activating astrocytes (Pankratov and Lalo, 2015). Activation of α1Rs also concurs to the anorexigenic effect of NE and amphetamines (da Silva et al., 2014).
A specific and consequential effect of α1R activation is emotion control. The decrease of the inhibitory drive onto the VTA may indicate an increase in motivation (Velásquez-Martínez et al., 2015). α1Rs are also clearly involved in the stress response, as revealed by acute restraint stress (Alves et al., 2014), predatory stress (Rajbhandari et al., 2015), and maternal separation (Coccurello et al., 2014) studies. In agreement with its role in the stress response, block of α1Rs impairs HPA activation (Yang et al., 2012).
Working memory and motor control
α1R positive modulation of working memory and other PFC function also seems to be solidly established by a wealth of data. For instance, α1R activation improves working memory deficit induced by applications of the GABAAR agonist muscimol (Hvoslef-Eide et al., 2015), while α1R block disrupts the “go” performance in a “go-no-go” task (Bari and Robbins, 2013). At the synaptic basis of these effects could lay an enhancement in glutamatergic function (Luo et al., 2014b, 2015a), which may, in turn, yield a general increase in firing frequency in the PFC (Zhang Z. et al., 2013). Other cellular and synaptic effects of α1R activation in the PFC, like an increase in inhibitory drive (Luo et al., 2015b) or a specific decrease in NMDAR-mediated response are not necessarily prone to similarly straightforward interpretations.
Motor effects of α1R activation appear to be associated with a generalized increase in motor activity (Villégier et al., 2003), accompanied by a reduced fine motor control (Aono et al., 2015), suggested also by improved rotarod performance of KO α1R mice (Mishima et al., 2004). A decreased glutamatergic cerebellar drive may concur to a reduced distal motor control (Lippiello et al., 2015).
Sensory modulation, memory, and learning
Even more puzzling are the effects of α1R activation on sensory activity. While the effectiveness of α1R activation on sensory areas appears to be well established, its overall function remains enigmatic, possibly due to opposite effects on excitatory and inhibitory synaptic systems, as well as to a genuine heterogeneity of the response to different sensory modalities. For instance, α1R activation increases firing in the somatosensory cortex (Devilbiss and Waterhouse, 2000), but decreases firing frequency and responses to glutamate in the visual (Terakado, 2014) and in the auditory cortex (Manunta and Edeline, 1997; Dinh et al., 2009). In the latter—in turn—activation of α1Rs elicits opposite responses on electrically-evoked GABAergic transmission originating from different cortical layers (Salgado et al., 2011, 2012a). αRs (possibly α1Rs) are involved in auditory cortex activity-dependent plasticity evoked by electric or optogenetic stimulation of LC (Martins and Froemke, 2015).
The olfactory bulb is also not exempt from displaying apparently contrasting α1R-induced effects, like an increase of GABAergic response (Zimnik et al., 2013) and membrane depolarization (Nai et al., 2009). The effects of α1R activation on sensory areas may be related to sensory modality selection after adrenergic activation, and/or maintenance of the excitatory/inhibitory balance following intense activation.
On the other hand, α1R activation elicits clearly positive effects on memory and learning (Doze et al., 2011), as corroborated by studies on constitutively active α1AR mentioned earlier (Collette et al., 2014), and by a worsened learning and working-memory related performance in KO α1R mice (Spreng et al., 2001). An increase in rebound excitation and neuronal ensemble synchronization associated with an α1R–mediated increase in GABA release in the entorhinal cortex (Lei et al., 2007; Cilz et al., 2014) may be at the root of at least some of the α1R–induced improvements in learning and memory.
Clinical data
Depression, psychosis, and numerous treatments for stress-related neuropsychiatric disease appear to modulate importantly α1Rs expression and function, although the direction of such modulation is not always consistent with illness or therapeutic effects. For instance, long-term administration of imipramine or electroconvulsive therapy increase the expression of α1Rs (Nalepa et al., 2002), but the antidepressant effects of other tricyclic antidepressants (TCAs) (Ramakrishna and Subhash, 2012) or quetiapine (Nikiforuk, 2013) reduce α1Rs expression. The interpretation of these results is further complicated by the age-dependence of α1Rs function (Deupree et al., 2007). Table 2 summarizes some of the systemic and cellular effects associated with α1Rs activation.
Table 2.
Measured or putative function of α1R activation | Brain area | α1R-related physiological effect | References |
---|---|---|---|
GENERAL ACTIVATION/METABOLISM | |||
Wake promoting | Preoptic area hypothalamus, medial septum | α1R (and βR) activation promotes wake | Schmeichel and Berridge, 2013 |
General activation | Overall brain, astrocytes | α1R induces Ca-waves, ATP release in astrocytes | Pankratov and Lalo, 2015 |
Hyperexcitability | LC | Persistent α1R activation increases hyperexcitability | Igata et al., 2014 |
Brain activation | Brain, systemic | α1R activation induces Ca-waves | Ding et al., 2013 |
Food intake | Medial raphe | α1 block induces food intake | da Silva et al., 2014 |
EMOTION/STRESS/MOOD/MOTIVATION | |||
Promotes motivation | VTA | α1R activation decreases GABAergic IPSC | Velásquez-Martínez et al., 2015 |
Promotes emotional response | Insular cortex | α1R (and α2R) activation induce systemic response to acute restraint stress | Alves et al., 2014 |
Postnatal stress increase α1R sensitivity (fear) | Amygdala | Predator stress increase α1R sensitivity | Rajbhandari et al., 2015 |
Prenatal stress decreases α1R sensitivity | Systemic/mice | Maternal separation induces α1R downregulation | Coccurello et al., 2014 |
Emotional memory | Amygdala | Chronic α1BR activation impaired passive avoidance | Knauber and Müller, 2000 |
HPA activation | Systemic | α1R block inhibits HPA stress response | Yang et al., 2012 |
Is modulated by chronic stress | Dorsal raphe | Chronic stress impairs α1R-induced LTD | Haj-Dahmane and Shen, 2014 |
PREFRONTAL CORTEX/EXECUTIVE FUNCTIONS | |||
Improves working memory | mPFC | α1R activation increases glutamate release | Luo et al., 2015a |
Increase working memory | mPFC | α1R activation increases mEPSC and response to pressure-applied AMPA and NMDA | Luo et al., 2014b |
Improves working memory | PFC | α1R activation improves muscimol-induced deficit in working memory | Hvoslef-Eide et al., 2015 |
Improves working memory | PFC | α1R (and α2R) activation induces persistent firing | Zhang Z. et al., 2013 |
Improves working memory | Systemic | Block of α1R receptor disrupts go performance | Bari and Robbins, 2013 |
Improves working memory | PFC | α1R prolong persistent activity (up-states) | Zhang Z. et al., 2013 |
Modulation of working memory | PFC | α1R activation decrease NMDA currents | Liu et al., 2006 |
Modulation of working memory | mPFC | α1R activation increases GABA inhibition | Luo et al., 2015b |
CONTROL OF MOVEMENT | |||
Motor control worsening | Basal ganglia | α1DR KO has improved motor coordination in rotarod | Mishima et al., 2004 |
Motor impairment | Nucleus accumbens | α1R activation impairs motility | Aono et al., 2015 |
Decrease cerebellar input/motor fine tuning | Cerebellar Purkinje cells | α1R activation decrease EPSC | Lippiello et al., 2015 |
Increase in locomotor activity | Systemic/overall brain | α1R agonists increase locomotor activity | Villégier et al., 2003 |
Regulation of walking/rearing/grooming | N. Accumbens | α1R (but NOT βR) are involved in reserpine-induced changes in behavior | Verheij et al., 2015 |
Decrease motor activity | Systemic | decreased exploratory activity | Knauber and Müller, 2000 |
SENSORY MODULATION/PLASTICITY | |||
Decreased excitability | Visual cortex | α1R activation decrease EPSC frequency, amplitude | Terakado, 2014 |
Increased excitability | Somatosensory cortex | α1R activation increase glutamate-induced firing | Devilbiss and Waterhouse, 2000 |
Decreased excitability | Auditory cortex | Iontophoretic application of α1R agonists decrease firing | Manunta and Edeline, 1997 |
Decreased excitability | Auditory cortex | α1R activation decrease glutamatergic response | Dinh et al., 2009 |
Increased excitability | Auditory cortex | α1R activation decreases GABAergic currents from cortical layer 1 | Salgado et al., 2011, 2012a |
Induces plasticity | Auditory cortex | Phentolamine blocks auditory cortex plasticity induced by electric/optogenetic LC stimulation | Martins and Froemke, 2015 |
Decreased excitability | Olfactory bulb | α1R activation increases GABAergic currents | Zimnik et al., 2013 |
Increased excitability | Olfactory bulb | α1R activation induces neuronal depolarization | Nai et al., 2009 |
MEMORY | |||
Memory modulation | Entorhinal cortex | α1R activation increases GABA release | Cilz et al., 2014 |
Increases learning and memory | PFC, hippocampus | α1AR stimulation improves cognition and learning capability | Doze et al., 2011 |
Increases learning and memory | PFC, hippocampus | α1BR KO mice have reduced learning capability | Spreng et al., 2001 |
Increases learning and memory | hippocampus | α1AR CAM live longer and have improved memory and learning | Collette et al., 2014 |
PATHOLOGY/MODELS | |||
Antidepressant effect | PFC | Age-dependent effect of tricyclic drugs on α1R expression | Deupree et al., 2007 |
Antidepressant effect | Cortex, cerebellum | Amytryptiline reduces α1R density | Ramakrishna and Subhash, 2012 |
Antidepressant effect, reverse cognitive impairment on an attention-shift task | PFC | Block of α1R by quetiapine | Nikiforuk, 2013 |
Antidepressant effect | Cortex, hippocampus | Electroconvulsive shock increases α1R expression | Nalepa et al., 2002 |
Contributes to drug addiction | BNST | α1R activation | McElligott and Winder, 2008 |
Induces mGlu insensitivity in depression | PFC rodent | α1R reduces GluR1 expression (induces downregulation) | Sekio and Seki, 2015 |
Drug seeking/mobility | Substantia Nigra | α1R activation induces drug seeking and promotes mobility | Goertz et al., 2015 |
βRs central modulation
Similar to α2Rs and α1Rs, the distribution of the various subtypes of βRs in the brain is almost ubiquitous in the mammalian brain (Paschalis et al., 2009; Ursino et al., 2009). βRs are, in fact, expressed in both excitatory and inhibitory cells in the cortex as well as in subcortical nuclei (Cox et al., 2008; Salgado et al., 2011; Liu et al., 2014). Among the latter, the amygdala is endowed with an especially high βRs density (Abraham et al., 2008).
Alertness, wake, and metabolism
Many functions identified for αRs are also brought about by βRs activation. One of them is wake and alertness (Schmeichel and Berridge, 2013). Especially interesting is the effect of βRs activation on astrocytes (Song et al., 2015; Dienel and Cruz, 2016; Sherpa et al., 2016), which induces a decrease in extracellular brain volume. βR are also neuroprotective (Laureys et al., 2014), and decrease endotoxin-induced toxicity (Jiang et al., 2015), possibly by eliciting process retraction in resting microglia (Gyoneva and Traynelis, 2013), in contrast with the induction of neurite growth in cultured cortical primary neurons (Day et al., 2014).
Cognition and sensory areas
βRs exert their effects in many sensory areas including the somatosensory cortex (Devilbiss and Waterhouse, 2000), the visual cortex (Terakado, 2014), the auditory cortex (Manunta and Edeline, 2004; Salgado et al., 2011), cochlear nucleus, lateral lemniscus, inferior colliculus (Wanaka et al., 1989), and the olfactory bulb (Shakhawat et al., 2015). Activation of βRs impairs sustained attention (Bari and Robbins, 2013), and increases the power (but not the frequency) of γ-oscillations (Haggerty et al., 2013), apparently without impairing cognitive flexibility (Steenbergen et al., 2015).
Similar to the sensory effects of αRs described in the previous sections, the effects of βRs do not necessarily appear to converge onto an unequivocal single function, representing either genuine differences between sensory areas, or recovery of the excitation/inhibition balance through adjustment of synaptic strength or other cellular mechanisms.
Limbic and motor function
The body of knowledge concerning the effects of βRs on a variety of limbic functions is remarkably consistent with the hypothesis that a high concentration of tonic NE is critical for eliciting or modulating emotion. Fear memory—for instance—is impaired after administration of βR blockers (Fitzgerald et al., 2015; Zhou et al., 2015), and βR activation interferes with fear extinction induced by novel stimuli (Liu et al., 2015). Interestingly, social stress generates microRNA which decreases fear response acting on βRs (Volk et al., 2014). These data indicate that βRs activation is unequivocally associated with fear and fear memory, most likely because of their high expression in the amygdala. βRs are also causally related to anxiety generation, as suggested by the anxiogenic effect of βR-agonist administration (Hecht et al., 2014), and corroborated by elegant experiments where βRs were activated via optogenetic means (Siuda et al., 2015). Interestingly, βR blockers also reduce the anxiogenic effect of cocaine intake (Wenzel et al., 2014), while βR agonist administration within the pre-Botzinger complex increases spontaneous sigh frequency (Viemari et al., 2013).
Perhaps not surprisingly, βRs are important mediators of stress effects. For instance, restraint stress reduces dopaminergic effects but not after blocking βRs (Chang and Grace, 2013). Along the same line, stress elevates LC release of NE, leading to desensitization of βRs, an effect that—if chronic—may give rise to a depressive behavioral phenotype (Porterfield et al., 2012). Motor function appears to be improved by βR activation. βR agonists increase cerebellar GABA input (Di Mauro et al., 2013), increase excitatory input to Purkinje cells, and decrease the threshold for cerebellar LTD (Lippiello et al., 2015), although worsening spatial orientation performance (Robinson et al., 2015).
Memory and learning
A wide experimental database supports a positive effect of βRs in learning and memory (Salgado et al., 2016). For instance, βR activation increases long-term potentiation (LTP) in the hippocampus and in the neocortex (Laing and Bashir, 2014; Hansen and Manahan-Vaughan, 2015; O'Dell et al., 2015) and memory retrieval, possibly by shutting down an after hyperpolarization activated (AHP) current (Zhang L. et al., 2013; Zhou et al., 2013), by “unsilencing” of silent synapses (Rozas et al., 2015), but also by inducing hippocampal long term depression (LTD; Goh and Manahan-Vaughan, 2013; Lethbridge et al., 2014).
βRs involvement in long-term synaptic plasticity is further indicated by the increased predisposition to long-term changes in both GABAergic synapses (Inoue et al., 2013) and glutamatergic synapses (Maity et al., 2015) following exposure to βRs or stress, in a βR-dependent manner (Grigoryan and Segal, 2013; Grigoryan et al., 2015).
Neuropsychiatric disease
The role of βRs in neurologic and psychiatric disease is an example of bell-shaped curve: on one hand, a βR deficit is associated with CNS malfunction and impairment, on the other one, it is a βRs hyperactivation causes distress and neurodegeneration. The former instance is epitomized by the βRs deficits associated with decreased LC-adrenergic function in aging (Santulli and Iaccarino, 2013). The finding of antibodies against βRs in the plasma of chronic fatigue syndrome (Loebel et al., 2016), and the improvement in memory (Dang et al., 2014) and cognitive performance (Phillips et al., 2016) in Down syndrome patients treated with βR agonist highlight the global importance of the βR-dependent component of noradrenergic transmission. The involvement of βRs in Alzheimer disease (AD) symptomatology is somehow controversial. For instance, βR activation appears to increase tau-protein phosphorylation—one of the hallmarks of AD (Wang et al., 2013), while routine presentation of novel stimuli is reported to protect from the toxicity from β-amyloid—another important AD marker—through βR activation (Li et al., 2013).
A βR-dependent increase in excitatory transmission in the bed nucleus stria terminalis (BNST) has been interpreted as distress factor in drug addiction seeking behavior (Egli et al., 2005), while βR block has been proposed as treatment for depression-related allodynia (Barrot et al., 2009). A possible general interpretation of the body of work related to the function of βRs in the context of stress is that short-term, acute, activation of βRs promotes demanding performances, whereas their chronic stimulation may lead to detrimental consequences of the same functions promoted by βRs short-term action. Table 3 summarizes recent experimental work on βR central function.
Table 3.
Measured or putative function of βR activation | Brain area | Cellular or synaptic effect | References |
---|---|---|---|
ALERTNESS/SLEEP + WAKE TRANSITION/METABOLISM | |||
Increase alertness, sensory processing, cognition, memory | Overall | βR activation is necessary for astrocyte aerobic glycolysis | Dienel and Cruz, 2016 |
Wake promoting | Overall | βR activation decrease extracellular volume | Sherpa et al., 2016 |
Wake promoting | Preoptic area hypothalamus medial septum | βR (and α1R) activation promotes wake | Schmeichel and Berridge, 2013 |
Wake promoting | Overall brain | βR activation increases astrocyte volume | Song et al., 2015 |
Decrease neuro-Inflammation | Cortex, hippocampus | βR activation suppress brain inflammation | Ryan et al., 2013 |
Modulates neuro-inflammation | Cortex | βR activation induces process retraction in resting microglia | Gyoneva and Traynelis, 2013 |
Induce neuroprotection | Overall brain | βR activation induces neuro-protection | Laureys et al., 2014 |
Protection from toxicity | Overall | βR activation decrease LPS-induced toxicity | Jiang et al., 2015 |
Induces axonal growth | Cortex | βR agonists activate glia and induce neurite growth | Day et al., 2014 |
Increase brain inflammation | Systemic | βR activation increase microglia cytokine production | Johnson et al., 2013 |
COGNITION | |||
Modulates Working memory/error detection/attention | mPFC | βR are present in mPFC GABAergic interneurons | Liu et al., 2014 |
Modulates cognition | Hippocampus | βR activation increase power (but not frequency) of gamma oscillations | Haggerty et al., 2013 |
Weakens working memory/error detection | mPFC | βR activation decreases glutamate release | Luo et al., 2014a |
Improves attention | Systemic | Block of βR impairs sustained attention | Bari and Robbins, 2013 |
Does not affect cognitive flexibility | Systemic cortex, human | Systemic βR block does not affect cognitive flexibility | Steenbergen et al., 2015 |
SENSORY ACTIVITY | |||
Mixed | Visual cortex | βR activation increases EPSCs | Terakado, 2014 |
βR activation increase EPSC amplitude and mIPSC frequency | |||
Excitation | Auditory cortex | βR agonists facilitate excitatory response | Manunta and Edeline, 2004 |
Mixed | Auditory cortex | βR agonists facilitate inhibitory response, increase in synchronization | Salgado et al., 2011 |
Inactivation | Somato-sensory cortex | βR activation decrease glutamate-induced firing | Devilbiss and Waterhouse, 2000 |
Slow down odor discrimination | Olfactory bulb | βR (and αR) blockage slowed odor discrimination | Shakhawat et al., 2015 |
EMOTION/ANXIETY/FEAR/FIGHT-OR-FLIGHT RESPONSE/STRESS | |||
Emotional memory | Amygdala | βR block decreases fear memory | Zhou et al., 2015 |
Decrease discrimination memory | Cortex/amygdala | βR block decrease high arousal induced discrimination memory | Conversi et al., 2014 |
Promote fear extinction | Amygdala | βR block worsens increase in fear extinction promoted by novel stimuli | Liu et al., 2015 |
Increase fear response | Amygdala | Interference microRNA generated by social chronic stress decrease fear response by decreasing βR activity | Volk et al., 2014 |
Fear conditioning | mPFC, amygdala | βR mediated PFC activity increase or decrease induced by fear conditioning | Fitzgerald et al., 2015 |
Induce anxiety | Amygdala | Peripheral βR activation increases anxiety | Leo et al., 2015 |
Cognitive effects/Induce anxiety | Cortex/amygdala | βR block improves cognition by blocking anxiety | Hecht et al., 2014 |
Induces anxiety | Amygdala | Activation of βRs with optogenetics induces anxiety | Siuda et al., 2015 |
Induce anxiety | Amygdala or BNST to VTA | βR block decreases anxiogenic effects of cocaine | Wenzel et al., 2014 |
Sighing frequency increase | Pre-botzinger complex brainstem | βR activation increases sigh frequency | Viemari et al., 2013 |
Stress adaptation | Amygdala | Restraint stress induces dopamine receptor downregulation through βRs | Chang and Grace, 2013 |
Stress sensitization | PFC, amygdala, hypothalamus | Stress increases NE turnover, desensitization of βR | Porterfield et al., 2012 |
Long-term changes | Overall | Acute stress induces gene and HPA axis activation | Roszkowski et al., 2016 |
MOVEMENT CONTROL/SPATIAL MEMORY | |||
Improves spatial orientation | Hippocampus | βR block worsens performance | Robinson et al., 2015 |
Improves fine tuning of motor control | Cerebellum | βR increases GABA response | Di Mauro et al., 2013 |
Increases cerebellar function | Cerebellar Purkinje cells | β activation increases EPSCs amplitude and lower LTP threshold | Lippiello et al., 2015 |
MEMORY AND LEARNING | |||
Increase Memory | PFC | βR activation increases LTP amplitude | Zhou et al., 2013 |
Memory retrieval | Hippocampus | βR activation decreases sAHP and increases memory retrieval | Zhang L. et al., 2013 |
Induce memory | Hippocampus | βR activation increases AMPARs insertion (unsilencing of silent synapses) | Rozas et al., 2015 |
Induce memory/Epigenetic changes | Overall | βR activation triggers epigenetic changes | Maity et al., 2016 |
Induce memory | DG hippoc | βR activation induces LTP | Hansen and Manahan-Vaughan, 2015 |
Induce memory | Hippocampus | βR activation increase metaplasticity of glutamatergic synapses | Maity et al., 2015 |
Induce memory | Hippocampus | βR activation increases LTP | O'Dell et al., 2015 |
Induce memory | Perirhinal cortex (medial temp lobe) | βR activation induces LTP from amygdala fibers but not within perirhinal cortex | Laing and Bashir, 2014 |
Induce episodic memory | Dentate Gyrus hippocampus | βR activation induces LTD | Lethbridge et al., 2014 |
Induce memory | Hippocampus CA1 | βR activation induces LTD | Goh and Manahan-Vaughan, 2013 |
Induce memory | Cortical synaptosomes | βrR activation increase glutamate release | Ferrero et al., 2013 |
Induce memory | Hippocampus | Prenatal stress decrease βR induction of LTP | Grigoryan and Segal, 2013 |
Induces Long-term changes in inhibitory circuits | PVN hypothalamus | βR activation induces metaplasticity at GABA synapses | Inoue et al., 2013 |
Early stress lower threshold for βRs LTP modulation | Hippocampus | Juvenile stress increase LTP sensitivity to βRs | Grigoryan et al., 2015 |
βRs IN NEUROPSYCHATRIC PATHOLOGY | |||
Aging | LC | Aging correlates with decrement in LC activity | Santulli and Iaccarino, 2013 |
Occurrence of chronic fatigue syndrome | Whole brain | Antibodies against βRs are evelated in Chronic Fatigue Syndrome | Loebel et al., 2016 |
Clinical improvement | LC | βR activation increases performance in Down syndrome | Phillips et al., 2016 |
Memory/Down syndrome | Hippocampus human down syndrome | βR activation improves memory in Down syndrome | Dang et al., 2014 |
Alzheimer prevention | Hippoc | Novelty activates βRs which protect from amyloid oligomer toxicity | Li et al., 2013 |
Induction of Alzheimer symptoms | Cortex, hippocampus | βR activation increase tau phosphorylation | Wang et al., 2013 |
Improve post-traumatic brain injury | Systemic | βR block reduces mortality rate | Ko et al., 2016 |
Distress induction in drug addiction (seeking) behavior. Intra-BNST βR antagonists inhibition of drug seeking behavior | Bed Nucleus Stria Terminalis | βR activation increases excitatory transmission | Egli et al., 2005 |
Depression treatment and antiallodynic effect | Systemic/clinic | βR block inhibits pain and decreases depression | Barrot et al., 2009 |
Use of β-blockers in the treatment of psychiatric disease
The high expression and high functional relevance of βRs in the amygdala and overall in the initiation of stress response would prompt them as target for pharmacological intervention in the treatment of stress-related psychiatric illness. Administration of the βR blockers, indeed, does decrease the behavioral and biochemical effects of social stress (Wohleb et al., 2011), of restraint stress (Tamburella et al., 2010), and shock-probe defensive burying response (Bondi et al., 2007), possibly by inhibiting cytokine release from microglia, among other effects (Wohleb et al., 2011). Promising results in the treatment of acute effects of stress come from the development of the blood-brain permeable β3R agonist amibegron (Stemmelin et al., 2008). Activation of βRs may be an important therapeutic component of the antidepressant effect of mirtazapine (Rauggi et al., 2005).
An old hypothesis positing that the therapeutic effect of antidepressant was due to downregulation of βRs (as elicited by TCA treatment; Peet and Yates, 1981) has long been discarded (Charney et al., 1986). βRs agonists have been proposed also in the treatment of the memory impairment associated with psychotic schizophrenia, but the detrimental effects of βR-agonists on working memory and general cognitive flexibility, prevent their routine use (Friedman et al., 2004). In spite of a clear involvement of βRs (and CRH receptors) in amygdala activation in the etiology of PTSD, less or no effective has been the use of βR blocker in the long-term treatment of post-traumatic stress disorder (PTSD; Amos et al., 2014) and schizophrenia (Wahlbeck et al., 2000). βR blockers lack of effectiveness may perhaps be explained by the occurrence of βR internalization induced by their persistent activation. βR internalization was one of the first β-arrestin mediated processes to be described (reviewed in DeWire et al., 2007). Neurons have among the highest expression of non-visual β-arrestin in the whole mammalian body (Gainetdinov et al., 2004). Stress activates β-arrestin mediated internalization of βRs as well as internalization of corticotropin-releasing hormone (CRH) type 1 receptors (Hauger et al., 2009). Either process is an important mechanism of neuronal desensitization to stress response. A related third neuronal desensitization process is the G-protein receptor kinase (GRK)—mediated switch of G-protein functioning from its classic pathway (adenylyl cyclase activation through Gs, in the case of βRs) to a ERK-only pathway (Hauger et al., 2009). This process prevents short-term action of βRs (Gs-induced activation of adenylyl cyclase) but potentially triggers longer-term mechanism like mitogen activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK), synaptogenesis, and, possibly, maladaptive synaptic plasticity.
LC-CNS interactions
As discussed earlier, the activation of the PFC-LC-PFC axis is critically important in the stress response (Itoi and Sugimoto, 2010). The extent of the involvement of the LC/central adrenergic system in the coordination of organism sensory input, decision-making, and motor execution suggests that the LC/NE system plays a critical role in the coordination of all stages of the spatio-temporal pattern of brain activation from quiet wake to periods of intense metabolic demand/stress. At the high end of metabolic demand, detrimental consequences of stress-evoked release of NE may derive from multiple factors, including the simultaneous abnormal release of cytokines—particularly interleukin 6 (IL-6; Li et al., 2015)—which by itself may lead to a wide array of psychiatric consequences from depression to psychosis and anxiety disorders (Atzori et al., 2012). Not surprisingly, an increase in the adrenergic (as well as dopaminergic) tone is an essential component of drug-induced “high” (Weinshenker and Schroeder, 2007; Sofuoglu and Sewell, 2009; Fitzgerald, 2013), similar to catecholamine hyper-function during psychotic episodes (Fitzgerald, 2014). An altered sensitivity of adrenergic receptors, or their abnormal function, may thus be a factor shared by a variety of stress-related psychiatric diseases, including post-traumatic stress disorder (George et al., 2013), generalized anxiety (Goddard et al., 2010), fibromyalgia (Clauw, 2014), as well as attention-deficit disorder (Chandler, 2015; Sterley et al., 2016).
We speculate that in a similar fashion, other areas showing differential adrenergic modulation are the motor cortex/cerebellum/striatum complex—responsible for commencing, coordinating, and carrying out rehearsed motor routines and impulsive behavior—as well as the heterogeneous group of brain areas labeled as Limbic System, which generate a variety of positive, negative, and mixed emotional states. The presence of strong anatomical projections from corticotropin-releasing hormone (CRH)-producing limbic areas to the LC is consistent with the hypothesis that negative mood may be a strong trigger for LC activity increase, at least in a physiological functioning brain.
We previously defined as stress any circumstance that raises the energy demand above an expected or biologically bearable threshold. Keeping in mind this idea, the steady-state energetic need of different fully-activated cortical areas varies greatly. For instance, limbic areas appear to be active even during sleep (default network; Buckner et al., 2008), with minimal energy demand. Purely sensory tasks, accompanied by sensory cortex activation, are likely to be the next least energetically demanding areas, as they are endowed with inbuilt circuitry for passive activity during the wake state. On the contrary, effective motor activity requires a combination of intention and sensory-motor coordination, which sets the motor circuitry to a relatively high-energy-demanding position. The highest energy need is requested by the prefrontal cortex, whose “working memory” juggles between multiple tasks including attention, planning future actions based on the retrieval of behavioral rules and sensory information stored earlier, and inhibition of momentary impulse. In addition, a high tone of limbic areas may drive high energy consumption from the PFC, to which is anatomically and functionally bi-directionally connected. It is likely, then, that stress affects to different extents brain areas with different stress-imposed additional energy requirement. Cortical areas in Figure 5 are numbered (1–4) in order of increasing energy need (anticlockwise), starting from limbic areas (1, lower right), sensory areas (2, upper right), motor areas (3, upper left), up to the prefrontal cortex (4, lower left).
LC-NE induced activation states
Good evidence exists for gap-junction mediated synchronous LC activation (Ishimatsu and Williams, 1996; Rash et al., 2007). Computational modeling supports the hypothesis of simultaneous activation of LC neurons, and simultaneous increase in brain NE (Gao and Holmes, 2007; Patel and Joshi, 2015), although alternative hypothesis have been proposed (Chandler et al., 2014a,b; Chandler, 2015). These observations suggest that different brain states may be elicited by increasing NE concentrations progressively activating ARs from high to low affinity for NE. In each of these states a different combination of tonic and phasic NE levels would give rise to regional differences in the brain activity, as well as to specific patterns of global function. In this section we will describe a largely speculative proposal for a sequence of cortical states in the order of progressively higher energy demand (Constantinople and Bruno, 2011), higher CNS NE levels, and progressive binding to the sequence of adrenoceptors α2R, α1R, and βRs in the order of affinity from the highest to the lowest (Figure 6). The intensity of gray indicates the level of physiological (non-pathological) activation, the thickness of the arrows indicates the strength of the connectivity between areas.
Sleep is the lowest-energy state, corresponding to a virtual absence of adrenergic tone. The whole organism—particularly the CNS—refills metabolic energy stores depleted during the previous wake phases. During this metabolic stage the organism is able to carry out important low-energy demand functions which do not require behavioral performance, like maintenance immune functions, rehearsal of mnemonic segments (Foster and Wilson, 2006) or motor sequence silent replay (Barnes and Wilson, 2014), aimed to synaptic stabilization and episodic or procedural memory consolidation.
The second state in the energy-demand ladder (quiet wake) is associated to low LC tonic firing, an active reward system, and mostly positive emotion in limbic areas. In this circumstance, the VTA releases dopamine that stabilizes the motivation axis represented by LC-Nucleus Accumbens-PFC receiving further input from the limbic cortices, and producing an optimal balance in the activity and reciprocal interaction among cortical areas and between cortical and subcortical regions. This state is characterized by optimal and flexible exchange of information between cortical areas and a relatively low physical and mental energetic load. In terms of LC activation/NE release, is associated with low but not nihil LC tonic firing and a high dynamic range for phasic LC responses to novel or salient stimuli, while, in terms of adrenoceptor activation, corresponds to tonic activation of α2 adrenoceptors, sporadic activation of α1Rs, and memory-promoting activation of βRs during phasic LC activation.
Tonic NE concentrations in the α1R activation range would promote a third condition (active wake) represented by a series of states characterized by selective activity-dependent enhancement of energy consumption in particular cortical areas. Such areas would be selected depending on the specific demands of the circumstance, driven by a relatively high emotional tone in limbic areas. For instance, during strenuous physical activity, strong sensory engagement, or critical behavioral planning, NE released from LC would selectively depress the activity in non-critical cortical areas in an α1R-dependent fashion, through depression of glutamatergic synapses (Dinh et al., 2009; Roychowdhury et al., 2014). At the same time, NE release would enhance energy consumption in critical cortical area(s) (i.e., motor controlling, sensory areas, working memory, or other brain areas) in an activity-dependent fashion, through a combination of phasically activated α1- and β-AR activation. This state would be associated with a relatively high tonic level of LC firing, a limited range of phasic LC responses to salient or new stimuli, and a decreased but still functional communication between different cortical areas. In the “active wake” state, an in-built circuitry, prepared by evolution for automatic processing, would promote strong but not overwhelming activity in sensory areas, motor areas, as well as in the PFC. The latter would elaborate variable strategies to resolve the specific demands of the contingency for which automatic processing is not effective. In social mammals, extinguishing a stressor may require an additional inter-individual interaction (social) component that overburdens the limbic system and is therefore especially vexing on the individual.
At the physiological highest level of energy consumption, the LC would display the strongest tonic activation, high tonic NE release, and a limited or inexistent range of phasic NE release, corresponding to the “fight-or-flight” (FoF) response described in the pioneering work of Cannon reviewed in Fee and Brown (2002), at the extreme of which could lay the berserk condition. This state is characterized by strong activation of cortical βARs, strong negative or positive emotion, impulsive response, deficient sensory activity, shut-down of the planning (PFC) areas, and scant or inefficient intra-cortical communication (Holmes and Wellman, 2009). This condition would be terminated with either of two outcomes: (1) the elimination of the stressor, resetting of LC activity to low tonic state, reactivation of a temporarily inhibited dopaminergic system, and return of the system to a low-energy state (sleep or idle wake), or, on the opposite end (2) failure to eliminate the stressor, depletion of organic energy reserve, and, possibly onset of long-term deficit or even death. In humans, this condition may give rise to neuropsychiatric disorder including epilepsy, burn-out syndrome, psychosis, depression, or anxiety, depending on the stressor pattern, individual genetic predisposition, and previous life history.
The maximum duration and intensity of high-energy states (active wake and distress/FoF) bearable by a specific individual would display significant inter-individual differences related to genetics, previous training/experience, and motivational state, and strongly depends on the history of the subject, to the point that periodic and controlled incursions into the stress state may be beneficial to increase the probability of successfully extinguishing unexpected future stressors. The hypothesis is graphically summarized by the sketches in Figures 5, 6.
An oft found bell-shaped dependence of specific PFC-dependent performance on adrenergic activation (Roychowdhury et al., 2012; Sapolsky, 2015) could be interpreted as a transition from a low-energy state (state 2: quiet wake), to state 3 (active wake), associated with a larger energy mobilization, stronger engagement, and improved cognitive performance (left part of the bell shape curve). At the right end of the curve would lay the transition between state 3 (stress) and state 4 (FoF, right part of the bell shape), with a massive engagement of βRs in the cortex as well as in subcortical nuclei—particularly the amygdala—and consequent dysfunctional working memory, in favor of an optimal impulsive, automatic, motor response and full-fledged autonomic sympathetic response (Bouret and Sara, 2005; Hains and Arnsten, 2008; Gamo and Arnsten, 2011). Needless to say, a comprehensive theory of energy mobilization in high-demanding states (active wake and distress/FoF) should include the role of other global transmitters, particularly acetylcholine, histamine, and 5HT. Such discussion is left for important future work, and falls outside the scope of this review.
It is tempting to speculate further that the regional pattern of energy consumption in this condition may have changed in the course of mammalian evolution, and possibly along mankind history, such that the effects of stress on motor and sensory cortices used to be a lot more severe during early history/evolution/developmental stages, compared with the effects on the PFC, while the latter has become (is becoming) the major subject—and potential victim—of stress in modern society, particularly for adolescent and adult humans.
Clinical consequences of stress-induced maladaptive plasticity
Stress notoriously impairs the dynamic balance between sympathetic and parasympathetic autonomic branches, affecting sleep, digestion, endocrine function, by altering the balance between peripheral parasympathetic and sympathetic tones (Grippo and Johnson, 2009; Silvani et al., 2016). Even more consequential, in the CNS, physiological stress of high intensity and/or prolonged duration may lead to β arrestin-mediated internalization of adrenergic receptors, studied in detail for βRs (Stone and Quartermain, 1999), leading in turn to a de-sensitization of βR-mediated central adrenergic pathways (Fu and Xiang, 2015). A possible consequence of intense or prolonged stress could be a decrease in effectiveness of the LC adrenergic system, leading to a decrease in the expression of the β1R type (Porterfield et al., 2012) in limbic areas, and to a change in the expression of βR-related effectors in other parts of the limbic system like the hippocampus (Benes et al., 2004).
We represented the two poles of LC/NE function with two examples each, in Figure 7 (LC hypofunction) and Figure 8 (LC hyperfunction). In these figures, red and yellow represent pathologically hyper- or hypo-active areas, respectively. The intensity of the blue stripes inside LC sketch (light in Figure 7 and strong in Figure 8) represents the level of tonic LC activation. As example of LC hypofunction we represented attention deficit disorder with hyperactivity (ADHD), in which a monoaminergic hypofunction yields a hypofunctional PFC, which in turn fails to exert a satisfactory inhibitory control on automatic motor activity, associated with sensory distractibility (Figure 7, left). While other monoaminergic deficits (principally dopaminergic) are most likely also involved in ADHD, the efficacy of the NE-reuptake inhibitors like atomoxetine in ADHD treatment corroborates the notion that an LC/NE deficit is a critical component of this condition.
While the causes and mechanisms of clinical depression involve factors other than the LC/NE system, a similar pharmacological argument—the efficacy of selective serotonin/norepinephrine reuptake inhibitors (SNRIs)—also indicates that a deficient noradrenergic system plays a critical role in the treatment of this affliction. In our hypothesis, depression—like ADHD—is also associated with a LC/NE and PFC deficit, but, compared to ADHD, is associated with opposite roles of limbic (hyperactive in depression) and motor (hypoactive in depression) areas (Figure 7, right).
As examples of conditions associated with long-term consequences (maladaptive plasticity) of LC hyper-function we selected anxiety disorder (Figure 8, left) and psychosis (Figure 8, right). Anxiety disorders are characterized by hyperactivation of the limbic-sensory axis, with a prevalence of a reality-detached negative mood. Different anxiety disorders may be associated with different degrees of motor activation, ranging from aggression (like in post-traumatic stress disorder), to freezing (like in a rodent response to a predator). Remarkably, anxiety and depression would only differ in terms of motor areas (in)activation, suggesting that further maladaptive plasticity may quickly convert an anxious state into a full-fledged depression, and that the same subject may oscillate between two conditions, which could even take place simultaneously. The large co-morbidity of anxiety and depression (van Tol et al., 2010) corroborates our hypothesis.
An example of even more severe mental condition associated with LC hyperfunction is psychosis (Figure 8, right). This condition is associated with hyperfunction of most cortical areas, promoted by a high monoaminergic tone, leading, in turn, to severe PFC functional impairment. Signs of generalized cortical hyper-function are pathognomonic symptoms of psychosis, like paranoia and hallucinations, as well as aggression. In this condition, prolonged and/or intense stress elicits a type of maladaptive plasticity that sensitizes limbic and sensory areas leading to loss of touch with reality, and—in the most dramatic cases—aggression and gross working memory impairment. Clinical support for a strong involvement of the LC/NE system—together with other monoaminergic systems—in psychoses, is the precipitation of psychotic episodes after intake of drugs including legal or illegal NE and other monoaminergic re-uptake blockers. Up-regulation of α1Rs may be a component of PFC impairment observed in the ventral-hippocampal lesion model of schizophrenia (Al-Khairi et al., 2009).
Depression and psychosis share the traits of working memory impairment, some level of detachment from reality, and hypersensitivity of limbic and sensory system, all of which can be triggered by prolonged or intense stress. Clinically, these two conditions may thus represent the result of a parallel process of stress-induced maladaptive plasticity landing on opposite poles of motor drive because of genetics or cultural factor. The similarities between depression and psychosis may explain the presence of both conditions (plus bipolar disease) associated with genes including DISC1 and neuregulins (Blackwood et al., 2007). This hypothesis is further supported by the finding of a reduced monoaminergic drive in a DISC1 animal model displaying depressive symptoms (Lipina et al., 2013).
Conclusions
Many unanswered questions remain about the role of the LC/NE system. While the presence of gap junctions within the LC has been suggested by anatomical (Rash et al., 2007) and functional (Ishimatsu and Williams, 1996) studies, to our knowledge, synchronous and proportional release of NE in different brain areas following LC activation has not yet been shown unambiguously. The question about simultaneous increase in NE concentration in different brain regions might be answered with precise—in time and space—measurement of monoamine levels, possibly with future developments of already existing electrochemical and microdialysis techniques.
Understanding the nature and extent of the interference between the noradrenergic system and other alertness- and attention-related modulator systems, notably, the serotoninergic, the histaminergic, and the cholinergic systems, and the possible specific role of each neurotransmitter in the global coordination of brain activity is also of critical importance. The presence of reciprocal presynaptic hetero-receptors between neurotransmitters pairs (including GABA and glutamate) may offer important and relatively unexplored mechanism of interaction between different modulatory systems. Hopefully, quantitative modeling will be able to pinpoint a precise correlation between global states induced by NE (and other modulators) and behavioral states.
Computational models reproducing experimental results (Gao and Holmes, 2007; Patel and Joshi, 2015), particularly on the roles of adrenoceptors in behavioral tasks (Chandler et al., 2014b; Chandler, 2015; Somkuwar et al., 2015) are starting to reach a remarkable level of sophistication, and will undoubtedly contribute to integrate the large amount of experimental results collected along many decades on the adrenergic effects on the modulation of intrinsic neuronal conductances and long- and short-term plasticity. Possibly the most important related issue concerns the specific mechanism through which distress elicits maladaptive plasticity, turning a number of physiologically connected, functional, brain areas into a series of dysfunctional circuits as seen in psychiatric disease.
An important and largely overlooked adrenergic mechanisms emerged in the last decade is the role of NE receptors in astrocyte and microglia modulation (O'Donnell et al., 2012; Pankratov and Lalo, 2015). Further, studies will be necessary to integrate the relationships among neuronal function, glial function, and noradrenergic activity.
Author contributions
MA wrote the article, RC, EE, FG, RS, NS, MM, MT, JP, and HS contributed by designing part of the manuscript structure, with intellectual contributions prior to the manuscript layout, and by writing parts of the manuscript, and revising its full extent. All authors have read, discussed, and accepted the final version of the manuscript.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
This work has been conducted in part with funds from CONACyT, CB-2013-01 221653 to MA.
References
- Abraham P. A., Xing G., Zhang L., Yu E. Z., Post R., Gamble E. H., et al. (2008). beta1- and beta2-adrenoceptor induced synaptic facilitation in rat basolateral amygdala. Brain Res. 1209, 65–73. 10.1016/j.brainres.2008.02.082 [DOI] [PubMed] [Google Scholar]
- Agnati L. F., Zoli M., Strömberg I., Fuxe K. (1995). Intercellular communication in the brain: wiring versus volume transmission. Neuroscience 69, 711–726. 10.1016/0306-4522(95)00308-6 [DOI] [PubMed] [Google Scholar]
- Al-Khairi I., Baharnoori M., Kamath A., Bhardwaj S. K., Srivastava L. K. (2009). Altered expression and alpha-1 adrenergic receptor mediated activity of protein kinase C in the prefrontal cortex of rats with neonatal ventral hippocampus lesions. Synapse 63, 1051–1059. 10.1002/syn.20691 [DOI] [PubMed] [Google Scholar]
- Alves F. H. F., Crestani C. C., Resstel L. B. M., Corrêa F. M. A. (2014). Both α1- and α2-adrenoceptors in the insular cortex are involved in the cardiovascular responses to acute restraint stress in rats. PLoS ONE 9:e83900. 10.1371/journal.pone.0083900 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Amos T., Stein D. J., Ipser J. C. (2014). Pharmacological interventions for preventing post-traumatic stress disorder (PTSD). Cochrane Database Syst. Rev. 7:CD006239. 10.1002/14651858.cd006239.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Aono Y., Taguchi H., Saigusa T., Uchida T., Takada K., Takiguchi H., et al. (2015). Simultaneous activation of the α1A-, α1B- and α1D-adrenoceptor subtypes in the nucleus accumbens reduces accumbal dopamine efflux in freely moving rats. Behav. Pharmacol. 26, 73–80. 10.1097/FBP.0000000000000113 [DOI] [PubMed] [Google Scholar]
- Arnsten A. F., Li B. M. (2005). Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol. Psychiatry 57, 1377–1384. 10.1016/j.biopsych.2004.08.019 [DOI] [PubMed] [Google Scholar]
- Arnsten A. F. T. (2011). catecholamine influences on dorsolateral prefrontal cortical networks. Biol. Psychiatry 69, e89–e99. 10.1016/j.biopsych.2011.01.027 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Arnsten A. F. T., Jin L. E. (2012). Guanfacine for the treatment of cognitive disorders: a century of discoveries at Yale. Yale J. Biol. Med. 85, 45–58. [PMC free article] [PubMed] [Google Scholar]
- Arnsten A. F. T., Jin L. E. (2014). Molecular influences on working memory circuits in dorsolateral prefrontal cortex. Prog. Mol. Biol. Transl. Sci. 122, 211–231. 10.1016/B978-0-12-420170-5.00008-8 [DOI] [PubMed] [Google Scholar]
- Arnsten A. F. T., Wang M. J., Paspalas C. D. (2012). Neuromodulation of thought: flexibilities and vulnerabilities in prefrontal cortical network synapses. Neuron 76, 223–239. 10.1016/j.neuron.2012.08.038 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Aston-Jones G., Cohen J. D. (2005). An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu. Rev. Neurosci. 28, 403–450. 10.1146/annurev.neuro.28.061604.135709 [DOI] [PubMed] [Google Scholar]
- Aston-Jones G., Rajkowski J., Ivanova S., Usher M., Cohen J. (1998). Neuromodulation and cognitive performance: recent studies of noradrenergic locus ceruleus neurons in behaving monkeys. Adv. Pharmacol. 42, 755–759. 10.1016/S1054-3589(08)60857-1 [DOI] [PubMed] [Google Scholar]
- Aston-Jones G., Waterhouse B. (2016). Locus Coeruleus: from global projection system to adaptive regulation of behavior. Brain Res. 1645, 75–78. 10.1016/j.brainres.2016.03.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Atzori M., Garcia-Oscos F., Mendez J. A. (2012). Role of IL-6 in the etiology of hyperexcitable neuropsychiatric conditions: experimental evidence and therapeutic implications. Future Med. Chem. 4, 2177–2192. 10.4155/fmc.12.156 [DOI] [PubMed] [Google Scholar]
- Bari A., Robbins T. W. (2013). Noradrenergic versus dopaminergic modulation of impulsivity, attention and monitoring behaviour in rats performing the stop-signal task: possible relevance to ADHD. Psychopharmacol. 230, 89–111. 10.1007/s00213-013-3141-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barnes D. C., Wilson D. A. (2014). Slow-wave sleep-imposed replay modulates both strength and precision of memory. J. Neurosci. 34, 5134–5142. 10.1523/JNEUROSCI.5274-13.2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barrot M., Yalcin I., Choucair-Jaafar N., Benbouzid M., Freund-Mercier M.-J. (2009). From antidepressant drugs to beta-mimetics: preclinical insights on potential new treatments for neuropathic pain. Recent Pat. CNS Drug Discov. 4, 182–189. 10.2174/157488909789104794 [DOI] [PubMed] [Google Scholar]
- Bencsics A., Elenkov I. J., Vizi E. S. (1995). alpha 2-, alpha 2A-, alpha 2B/2C-Adrenoceptor subtype antagonists prevent lipopolysaccharide-induced fever response in rabbits. Brain Res. 705, 302–306. 10.1016/0006-8993(95)01154-4 [DOI] [PubMed] [Google Scholar]
- Benes F. M., Burke R. E., Walsh J., Berretta S., Matzilevich D., Minns M., et al. (2004). Acute amygdalar activation induces an upregulation of multiple monoamine G protein coupled pathways in rat hippocampus. Mol. Psychiatry 9, 932–945. 10.1038/sj.mp.4001524 [DOI] [PubMed] [Google Scholar]
- Berridge C. W., Waterhouse B. D. (2003). The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res. Brain Res. Rev. 42, 33–84. 10.1016/S0165-0173(03)00143-7 [DOI] [PubMed] [Google Scholar]
- Blackwood D. H. R., Pickard B. J., Thomson P. A., Evans K. L., Porteous D. J., Muir W. J. (2007). Are some genetic risk factors common to schizophrenia, bipolar disorder and depression? Evidence from DISC1, GRIK4 and NRG1. Neurotox. Res. 11, 73–83. 10.1007/BF03033484 [DOI] [PubMed] [Google Scholar]
- Bondi C. O., Barrera G., Lapiz M. D. S., Bedard T., Mahan A., Morilak D. A. (2007). Noradrenergic facilitation of shock-probe defensive burying in lateral septum of rats, and modulation by chronic treatment with desipramine. Prog. Neuropsychopharmacol. Biol. Psychiatry 31, 482–495. 10.1016/j.pnpbp.2006.11.015 [DOI] [PubMed] [Google Scholar]
- Bouret S., Sara S. J. (2005). Network reset: a simplified overarching theory of locus coeruleus noradrenaline function. Trends Neurosci. 28, 574–582. 10.1016/j.tins.2005.09.002 [DOI] [PubMed] [Google Scholar]
- Brennan A. R., Arnsten A. F. (2008). Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function. Ann. N.Y. Acad. Sci. 1129, 236–245. 10.1196/annals.1417.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brown D. C., Co M. S., Wolff R. C., Atzori M. (2012). alpha-Adrenergic receptors in auditory cue detection: alpha(2) receptor blockade suppresses false alarm responding in the rat. Neuropharmacology 62, 2178–2183. 10.1016/j.neuropharm.2011.12.024 [DOI] [PubMed] [Google Scholar]
- Buckner R. L., Andrews-Hanna J. R., Schacter D. L. (2008). The brain's default network: anatomy, function, and relevance to disease. Ann. N.Y. Acad. Sci. 1124, 1–38. 10.1196/annals.1440.011 [DOI] [PubMed] [Google Scholar]
- Carey M. R., Regehr W. G. (2009). Noradrenergic control of associative synaptic plasticity by selective modulation of instructive signals. Neuron 62, 112–122. 10.1016/j.neuron.2009.02.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carr D. B., Andrews G. D., Glen W. B., Lavin A. (2007). alpha2-Noradrenergic receptors activation enhances excitability and synaptic integration in rat prefrontal cortex pyramidal neurons via inhibition of HCN currents. J. Physiol. (Lond). 584, 437–450. 10.1113/jphysiol.2007.141671 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carter M. E., Brill J., Bonnavion P., Huguenard J. R., Huerta R., de Lecea L. (2012). Mechanism for Hypocretin-mediated sleep-to-wake transitions. Proc. Natl. Acad. Sci. U.S.A. 109, E2635–E2644. 10.1073/pnas.1202526109 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cathala L., Guyon A., Eugene D., Paupardin-Tritsch D. (2002). Alpha2-adrenoceptor activation increases a cationic conductance and spontaneous GABAergic synaptic activity in dopaminergic neurones of the rat substantia nigra. Neuroscience 115, 1059–1065. 10.1016/S0306-4522(02)00542-0 [DOI] [PubMed] [Google Scholar]
- Cathel A. M., Reyes B. A. S., Wang Q., Palma J., Mackie K., Van Bockstaele E. J., et al. (2014). Cannabinoid modulation of alpha2 adrenergic receptor function in rodent medial prefrontal cortex. Eur. J. Neurosci. 40, 3202–3214. 10.1111/ejn.12690 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chandler D. J. (2015). Evidence for a specialized role of the locus coeruleus noradrenergic system in cortical circuitries and behavioral operations. Brain Res. 1641, 197–206. 10.1016/j.brainres.2015.11.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chandler D. J., Gao W.-J., Waterhouse B. D. (2014a). Heterogeneous organization of the locus coeruleus projections to prefrontal and motor cortices. Proc. Natl. Acad. Sci. U.S.A. 111, 6816–6821. 10.1073/pnas.1320827111 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chandler D. J., Waterhouse B. D., Gao W.-J. (2014b). New perspectives on catecholaminergic regulation of executive circuits: evidence for independent modulation of prefrontal functions by midbrain dopaminergic and noradrenergic neurons. Front. Neural Circuits 8:53. 10.3389/fncir.2014.00053 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chang C., Grace A. A. (2013). Amygdala β-noradrenergic receptors modulate delayed downregulation of dopamine activity following restraint. J. Neurosci. 33, 1441–1450. 10.1523/JNEUROSCI.2420-12.2013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Charney D. S., Price L. H., Heninger G. R. (1986). Desipramine-yohimbine combination treatment of refractory depression. Implications for the beta-adrenergic receptor hypothesis of antidepressant action. Arch. Gen. Psychiatry 43, 1155–1161. 10.1001/archpsyc.1986.01800120041009 [DOI] [PubMed] [Google Scholar]
- Chmielarz P., Kuśmierczyk J., Parlato R., Schütz G., Nalepa I., Kreiner G. (2013). Inactivation of glucocorticoid receptor in noradrenergic system influences anxiety- and depressive-like behavior in mice. PLoS ONE 8:e72632. 10.1371/journal.pone.0072632 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chong W., Li L. H., Lee K., Lee M. H., Park J. B., Ryu P. D. (2004). Subtypes of alpha1- and alpha2-adrenoceptors mediating noradrenergic modulation of spontaneous inhibitory postsynaptic currents in the hypothalamic paraventricular nucleus. J. Neuroendocrinol. 16, 450–457. 10.1111/j.1365-2826.2004.01180.x [DOI] [PubMed] [Google Scholar]
- Cilz N. I., Kurada L., Hu B., Lei S. (2014). Dopaminergic modulation of GABAergic transmission in the entorhinal cortex: concerted roles of α1 adrenoreceptors, inward rectifier K+, and T-type Ca2+ channels. Cereb. Cortex 24, 3195–3208. 10.1093/cercor/bht177 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Clauw D. J. (2014). Fibromyalgia: a clinical review. JAMA 311, 1547–1555. 10.1001/jama.2014.3266 [DOI] [PubMed] [Google Scholar]
- Coccurello R., Bielawski A., Zelek-Molik A., Vetulani J., Kowalska M., D'Amato F. R., et al. (2014). Brief maternal separation affects brain α1-adrenoceptors and apoptotic signaling in adult mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 48, 161–169. 10.1016/j.pnpbp.2013.10.004 [DOI] [PubMed] [Google Scholar]
- Collette K. M., Zhou X. D., Amoth H. M., Lyons M. J., Papay R. S., Sens D. A., et al. (2014). Long-term α1B-adrenergic receptor activation shortens lifespan, while α1A-adrenergic receptor stimulation prolongs lifespan in association with decreased cancer incidence. Age 36, 9675. 10.1007/s11357-014-9675-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Constantinople C. M., Bruno R. M. (2011). Effects and mechanisms of wakefulness on local cortical networks. Neuron 69, 1061–1068. 10.1016/j.neuron.2011.02.040 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Conversi D., Cruciani F., Accoto A., Cabib S. (2014). Positive emotional arousal increases duration of memory traces: different role of dopamine D1 receptor and β-adrenoceptor activation. Pharmacol. Biochem. Behav. 122, 158–163. 10.1016/j.pbb.2014.04.001 [DOI] [PubMed] [Google Scholar]
- Cottingham C., Ferryman C. J., Wang Q. (2015). α2 Adrenergic receptor trafficking as a therapeutic target in antidepressant drug action. Prog. Mol. Biol. Transl. Sci. 132, 207–225. 10.1016/bs.pmbts.2015.03.007 [DOI] [PubMed] [Google Scholar]
- Cox D. J., Racca C., LeBeau F. E. N. (2008). Beta-adrenergic receptors are differentially expressed in distinct interneuron subtypes in the rat hippocampus. J. Comp. Neurol. 509, 551–565. 10.1002/cne.21758 [DOI] [PubMed] [Google Scholar]
- Dang V., Medina B., Das D., Moghadam S., Martin K. J., Lin B., et al. (2014). Formoterol, a long-acting β2 adrenergic agonist, improves cognitive function and promotes dendritic complexity in a mouse model of Down syndrome. Biol. Psychiatry 75, 179–188. 10.1016/j.biopsych.2013.05.024 [DOI] [PubMed] [Google Scholar]
- da Silva E. S., Flores R. A., Cella E. C., Levone B. R., Taschetto A. P., Kochenborger L., et al. (2014). Blockade of median raphe nucleus α1-adrenoceptor subtypes increases food intake in rats. Pharmacol. Biochem. Behav. 124, 350–355. 10.1016/j.pbb.2014.06.010 [DOI] [PubMed] [Google Scholar]
- Day J. S., O'Neill E., Cawley C., Aretz N. K., Kilroy D., Gibney S. M., et al. (2014). Noradrenaline acting on astrocytic β2-adrenoceptors induces neurite outgrowth in primary cortical neurons. Neuropharmacology 77, 234–248. 10.1016/j.neuropharm.2013.09.027 [DOI] [PubMed] [Google Scholar]
- De Kloet E. R. (2004). Hormones and the stressed brain. Ann. N.Y. Acad. Sci. 1018, 1–15. 10.1196/annals.1296.001 [DOI] [PubMed] [Google Scholar]
- Deupree J. D., Reed A. L., Bylund D. B. (2007). Differential effects of the tricyclic antidepressant desipramine on the density of adrenergic receptors in juvenile and adult rats. J. Pharmacol. Exp. Ther. 321, 770–776. 10.1124/jpet.106.118935 [DOI] [PubMed] [Google Scholar]
- Devilbiss D. M., Waterhouse B. D. (2000). Norepinephrine exhibits two distinct profiles of action on sensory cortical neuron responses to excitatory synaptic stimuli. Synapse 37, 273–282. [DOI] [PubMed] [Google Scholar]
- DeWire S. M., Ahn S., Lefkowitz R. J., Shenoy S. K. (2007). Beta-arrestins and cell signaling. Annu. Rev. Physiol. 69, 483–510. 10.1146/annurev.physiol.69.022405.154749 [DOI] [PubMed] [Google Scholar]
- Dienel G. A., Cruz N. F. (2016). Aerobic glycolysis during brain activation: adrenergic regulation and influence of norepinephrine on astrocytic metabolism. J. Neurochem. 138, 14–52. 10.1111/jnc.13630 [DOI] [PubMed] [Google Scholar]
- Di Mauro M., Li Volsi G., Licata F. (2013). Noradrenergic control of neuronal firing in cerebellar nuclei: modulation of GABA responses. Cerebellum 12, 350–361. 10.1007/s12311-012-0422-2 [DOI] [PubMed] [Google Scholar]
- Ding F., O'Donnell J., Thrane A. S., Zeppenfeld D., Kang H., Xie L., et al. (2013). α1-Adrenergic receptors mediate coordinated Ca2+ signaling of cortical astrocytes in awake, behaving mice. Cell Calcium 54, 387–394. 10.1016/j.ceca.2013.09.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dinh L., Nguyen T., Salgado H., Atzori M. (2009). Norepinephrine Homogeneously inhibits alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate- (AMPAR-) mediated currents in all layers of the temporal cortex of the rat. Neurochem. Res. 34, 1896–1906. 10.1007/s11064-009-9966-z [DOI] [PubMed] [Google Scholar]
- Doze V. A., Papay R. S., Goldenstein B. L., Gupta M. K., Collette K. M., Nelson B. W., et al. (2011). Long-term α1A-adrenergic receptor stimulation improves synaptic plasticity, cognitive function, mood, and longevity. Mol. Pharmacol. 80, 747–758. 10.1124/mol.111.073734 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Edeline J. M. (2012). Beyond traditional approaches to understanding the functional role of neuromodulators in sensory cortices. Front. Behav. Neurosci. 6:45. 10.3389/fnbeh.2012.00045 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Egli R. E., Kash T. L., Choo K., Savchenko V., Matthews R. T., Blakely R. D., et al. (2005). Norepinephrine modulates glutamatergic transmission in the bed nucleus of the stria terminalis. Neuropsychopharmacology, 30, 657–668. 10.1038/sj.npp.1300639 [DOI] [PubMed] [Google Scholar]
- Fee E., Brown T. (2002). Walter Bradford Cannon: pioneer physiologist of human emotions. Am. J. Public Health 92, 1594–1595. 10.2105/AJPH.92.10.1594 [DOI] [Google Scholar]
- Ferrero J. J., Alvarez A. M., Ramírez-Franco J., Godino M. C., Bartolomé-Martín D., Aguado C., et al. (2013). β-Adrenergic receptors activate exchange protein directly activated by cAMP (Epac), translocate Munc13-1, and enhance the Rab3A-RIM1α interaction to potentiate glutamate release at cerebrocortical nerve terminals. J. Biol. Chem. 288, 31370–31385. 10.1074/jbc.M113.463877 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fitzgerald P. J. (2013). Elevated Norepinephrine may be a unifying etiological factor in the abuse of a broad range of substances: alcohol, nicotine, marijuana, heroin, cocaine, and caffeine. Subst. Abuse 7, 171–183. 10.4137/sart.s13019 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fitzgerald P. J. (2014). Is elevated norepinephrine an etiological factor in some cases of schizophrenia? Psychiatry Res. 215, 497–504. 10.1016/j.psychres.2014.01.011 [DOI] [PubMed] [Google Scholar]
- Fitzgerald P. J., Giustino T. F., Seemann J. R., Maren S. (2015). Noradrenergic blockade stabilizes prefrontal activity and enables fear extinction under stress. Proc. Natl. Acad. Sci. U.S.A. 112, E3729–E3737. 10.1073/pnas.1500682112 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Foster D. J., Wilson M. A. (2006). Reverse replay of behavioural sequences in hippocampal place cells during the awake state. Nature 440, 680–683. 10.1038/nature04587 [DOI] [PubMed] [Google Scholar]
- Friedman J. I., Stewart D. G., Gorman J. M. (2004). Potential noradrenergic targets for cognitive enhancement in schizophrenia. CNS Spectr. 9, 350–355. 10.1017/S1092852900009330 [DOI] [PubMed] [Google Scholar]
- Fu Q., Xiang Y. K. (2015). Trafficking of β-adrenergic receptors: Implications in intracellular receptor signaling. Prog. Mol. Biol. Transl. Sci. 132, 151–188. 10.1016/bs.pmbts.2015.03.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fuxe K., Dahlström A. B., Jonsson G., Marcellino D., Guescini M., Dam M., et al. (2010). The discovery of central monoamine neurons gave volume transmission to the wired brain. Prog Neurobiol. 90, 82–100. 10.1016/j.pneurobio.2009.10.012 [DOI] [PubMed] [Google Scholar]
- Gainetdinov R. R., Premont R. T., Bohn L. M., Lefkowitz R. J., Caron M. G. (2004). Desensitization of G protein-coupled receptors and neuronal functions. Annu. Rev. Neurosci. 27, 107–144. 10.1146/annurev.neuro.27.070203.144206 [DOI] [PubMed] [Google Scholar]
- Gamo N. J., Arnsten A. F. (2011). Molecular modulation of prefrontal cortex: rational development of treatments for psychiatric disorders. Behav. Neurosci. 125, 282–296. 10.1037/a0023165 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gao J., Holmes P. (2007). On the dynamics of electrically-coupled neurons with inhibitory synapses. J. Comput. Neurosci. 22, 39–61. 10.1007/s10827-006-9676-3 [DOI] [PubMed] [Google Scholar]
- George S. A., Knox D., Curtis A. L., Aldridge J. W., Valentino R. J., Liberzon I. (2013). Altered locus coeruleus-norepinephrine function following single prolonged stress. Eur. J. Neurosci. 37, 901–909. 10.1111/ejn.12095 [DOI] [PubMed] [Google Scholar]
- Goddard A. W., Ball S. G., Martinez J., Robinson M. J., Yang C. R., Russell J. M., et al. (2010). Current perspectives of the roles of the central norepinephrine system in anxiety and depression. Depress. Anxiety 27, 339–350. 10.1002/da.20642 [DOI] [PubMed] [Google Scholar]
- Goertz R. B., Wanat M. J., Gomez J. A., Brown Z. J., Phillips P. E. M., Paladini C. A. (2015). Cocaine increases dopaminergic neuron and motor activity via midbrain α1 adrenergic signaling. Neuropsychopharmacology 40, 1151–1162. 10.1038/npp.2014.296 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goh J. J., Manahan-Vaughan D. (2013). Hippocampal long-term depression in freely behaving mice requires the activation of beta-adrenergic receptors. Hippocampus 23, 1299–1308. 10.1002/hipo.22168 [DOI] [PubMed] [Google Scholar]
- Gold P. W. (2015). The organization of the stress system and its dysregulation in depressive illness. Mol. Psychiatry 20, 32–47. 10.1038/mp.2014.163 [DOI] [PubMed] [Google Scholar]
- Gold P. W., Chrousos G. P. (2002). Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol. Psychiatry 7, 254–275. 10.1038/sj.mp.4001032 [DOI] [PubMed] [Google Scholar]
- Grigoryan G., Ardi Z., Albrecht A., Richter-Levin G., Segal M. (2015). Juvenile stress alters LTP in ventral hippocampal slices: involvement of noradrenergic mechanisms. Behav. Brain Res. 278, 559–562. 10.1016/j.bbr.2014.09.047 [DOI] [PubMed] [Google Scholar]
- Grigoryan G., Segal M. (2013). Prenatal stress alters noradrenergic modulation of LTP in hippocampal slices. J. Neurophysiol. 110, 279–285. 10.1152/jn.00834.2012 [DOI] [PubMed] [Google Scholar]
- Grippo A. J., Johnson A. K. (2009). Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models. Stress 12, 1–21. 10.1080/10253890802046281 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Groch S., Wilhelm I., Diekelmann S., Sayk F., Gais S., Born J. (2011). Contribution of norepinephrine to emotional memory consolidation during sleep. Psychoneuroendocrinology 36, 1342–1350. 10.1016/j.psyneuen.2011.03.006 [DOI] [PubMed] [Google Scholar]
- Grzanna R. M. M. (1980). The locus coeruleus in the rat: an immunohistochemical delineation. Neuroscience 5, 21–40. 10.1016/0306-4522(80)90068-8 [DOI] [PubMed] [Google Scholar]
- Guijarro A., Laviano A., Meguid M. M. (2006). Hypothalamic integration of immune function and metabolism. Prog. Brain Res. 153, 367–405. 10.1016/S0079-6123(06)53022-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gyoneva S., Traynelis S. F. (2013). Norepinephrine modulates the motility of resting and activated microglia via different adrenergic receptors. J. Biol. Chem. 288, 15291–15302. 10.1074/jbc.M113.458901 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Haggerty D. C., Glykos V., Adams N. E., Lebeau F. E. (2013). Bidirectional modulation of hippocampal gamma (20-80 Hz) frequency activity in vitro via alpha(alpha)- and beta(beta)-adrenergic receptors (AR). Neuroscience 253, 142–154. 10.1016/j.neuroscience.2013.08.028 [DOI] [PubMed] [Google Scholar]
- Hains A. B., Arnsten A. F. (2008). Molecular mechanisms of stress-induced prefrontal cortical impairment: implications for mental illness. Learn. Mem. 15, 551–564. 10.1101/lm.921708 [DOI] [PubMed] [Google Scholar]
- Haj-Dahmane S., Shen R.-Y. (2014). Chronic stress impairs α1-adrenoceptor-induced endocannabinoid-dependent synaptic plasticity in the dorsal raphe nucleus. J. Neurosci. 34, 14560–14570. 10.1523/JNEUROSCI.1310-14.2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hansen N., Manahan-Vaughan D. (2015). Locus coeruleus stimulation facilitates long-term depression in the dentate gyrus that requires activation of β-adrenergic receptors. Cereb. Cortex 25, 1889–1896. 10.1093/cercor/bht429 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Haroon E., Raison C. L., Miller A. H. (2012). Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 37, 137–162. 10.1038/npp.2011.205 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hauger R. L., Risbrough V., Oakley R. H., Olivares-Reyes J. A., Dautzenberg F. M. (2009). Role of CRF receptor signaling in stress vulnerability, anxiety, and depression. Ann. N.Y. Acad. Sci. 1179, 120–143. 10.1111/j.1749-6632.2009.05011.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hecht P. M., Will M. J., Schachtman T. R., Welby L. M., Beversdorf D. Q. (2014). Beta-adrenergic antagonist effects on a novel cognitive flexibility task in rodents. Behav. Brain Res. 260, 148–154. 10.1016/j.bbr.2013.11.041 [DOI] [PubMed] [Google Scholar]
- Heisler L. K., Cowley M. A., Kishi T., Tecott L. H., Fan W., Low M. J., et al. (2003). Central serotonin and melanocortin pathways regulating energy homeostasis. Ann. N.Y. Acad. Sci. 994, 169–174. 10.1111/j.1749-6632.2003.tb03177.x [DOI] [PubMed] [Google Scholar]
- Henny P., Brischoux F., Mainville L., Stroh T., Jones B. E. (2010). Immunohistochemical evidence for synaptic release of glutamate from orexin terminals in the locus coeruleus. Neuroscience 169, 1150–1157. 10.1016/j.neuroscience.2010.06.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hirono M., Obata K. (2006). Alpha-adrenoceptive dual modulation of inhibitory GABAergic inputs to Purkinje cells in the mouse cerebellum. J. Neurophysiol. 95, 700–708. 10.1152/jn.00711.2005 [DOI] [PubMed] [Google Scholar]
- Holmes A., Wellman C. L. (2009). Stress-induced prefrontal reorganization and executive dysfunction in rodents. Neurosci. Biobehav. Rev. 33, 773–783. 10.1016/j.neubiorev.2008.11.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hvoslef-Eide M., Oomen C. A., Fisher B. M., Heath C. J., Robbins T. W., Saksida L. M., et al. (2015). Facilitation of spatial working memory performance following intra-prefrontal cortical administration of the adrenergic alpha1 agonist phenylephrine. Psychopharmacology (Berl). 232, 4005–4016. 10.1007/s00213-015-4038-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Igata S., Hayashi T., Itoh M., Akasu T., Takano M., Ishimatsu M. (2014). Persistent α1-adrenergic receptor function in the nucleus locus coeruleus causes hyperexcitability in AD/HD model rats. J. Neurophysiol. 111, 777–786. 10.1152/jn.01103.2012 [DOI] [PubMed] [Google Scholar]
- Inoue W., Baimoukhametova D. V., Füzesi T., Wamsteeker Cusulin J. I., Koblinger K., Whelan P. J., et al. (2013). Noradrenaline is a stress-associated metaplastic signal at GABA synapses. Nat. Neurosci. 16, 605–612. 10.1038/nn.3373 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ishimatsu M., Williams J. T. (1996). Synchronous activity in locus coeruleus results from dendritic interactions in pericoerulear regions. J. Neurosci. 16, 5196–5204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Itoi K., Sugimoto N. (2010). The brainstem noradrenergic systems in stress, anxiety and depression. J. Neuroendocrinol. 22, 355–361. 10.1111/j.1365-2826.2010.01988.x [DOI] [PubMed] [Google Scholar]
- Ji X. H., Ji J. Z., Zhang H., Li B. M. (2008). Stimulation of alpha2-adrenoceptors suppresses excitatory synaptic transmission in the medial prefrontal cortex of rat. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 33, 2263–2271. 10.1038/sj.npp.1301603 [DOI] [PubMed] [Google Scholar]
- Jiang L., Chen S.-H., Chu C.-H., Wang S.-J., Oyarzabal E., Wilson B., et al. (2015). A novel role of microglial NADPH oxidase in mediating extra-synaptic function of norepinephrine in regulating brain immune homeostasis. Glia 63, 1057–1072. 10.1002/glia.22801 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jiménez-Rivera C. A., Figueroa J., Vázquez-Torres R., Vélez-Hernandez M. E., Schwarz D., Velásquez-Martinez M. C., et al. (2012). Presynaptic inhibition of glutamate transmission by α2 receptors in the VTA. Eur. J. Neurosci. 35, 1406–1415. 10.1111/j.1460-9568.2012.08029.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- Johnson J. D., Zimomra Z. R., Stewart L. T. (2013). Beta-adrenergic receptor activation primes microglia cytokine production. J. Neuroimmunol. 254, 161–164. 10.1016/j.jneuroim.2012.08.007 [DOI] [PubMed] [Google Scholar]
- Jones B. E., Yang T. Z. (1985). The efferent projections from the reticular formation and the locus coeruleus studied by anterograde and retrograde axonal transport in the rat. J. Comp. Neurol. 242, 56–92. 10.1002/cne.902420105 [DOI] [PubMed] [Google Scholar]
- Kamath J., Prpich G., Jillani S. (2015). Sleep disturbances in patients with medical conditions. Psychiatr. Clin. North Am. 38, 825–841. 10.1016/j.psc.2015.07.011 [DOI] [PubMed] [Google Scholar]
- Kitchigina V. F., Kutyreva E. V., Brazhnik E. S. (2003). Modulation of theta rhythmicity in the medial septal neurons and the hippocampal electroencephalogram in the awake rabbit via actions at noradrenergic alpha2-receptors. Neuroscience 120, 509–521. 10.1016/S0306-4522(03)00331-2 [DOI] [PubMed] [Google Scholar]
- Knauber J., Müller W. E. (2000). Decreased exploratory activity and impaired passive avoidance behaviour in mice deficient for the alpha(1b)-adrenoceptor. Eur. Neuropsychopharmacol. 10, 423–427. 10.1016/S0924-977X(00)00100-0 [DOI] [PubMed] [Google Scholar]
- Ko A., Harada M. Y., Barmparas G., Thomsen G. M., Alban R. F., Bloom M. B., et al. (2016). Early propranolol after traumatic brain injury is associated with lower mortality. J. Trauma Acute Care Surg. 80, 637–642. 10.1097/TA.0000000000000959 [DOI] [PubMed] [Google Scholar]
- Kovács P., Hernádi I. (2003). Alpha2 antagonist yohimbine suppresses maintained firing of rat prefrontal neurons in vivo. Neuroreport 14, 833–836. 10.1097/00001756-200305060-00011 [DOI] [PubMed] [Google Scholar]
- Laing M., Bashir Z. I. (2014). β-Adrenoceptors and synaptic plasticity in the perirhinal cortex. Neuroscience 273, 163–173. 10.1016/j.neuroscience.2014.04.070 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Laureys G., Valentino M., Demol F., Zammit C., Muscat R., Cambron M., et al. (2014). β2-adrenergic receptors protect axons during energetic stress but do not influence basal glio-axonal lactate shuttling in mouse white matter. Neuroscience 277, 367–374. 10.1016/j.neuroscience.2014.07.022 [DOI] [PubMed] [Google Scholar]
- Leão R. M., Von Gersdorff H. (2002). Noradrenaline increases high-frequency firing at the calyx of Held synapse during development by inhibiting glutamate release. J. Neurophysiol. 87, 2297–2306. [DOI] [PubMed] [Google Scholar]
- Lee A., Rosin D. L., Van Bockstaele E. J. (1998). alpha2A-adrenergic receptors in the rat nucleus locus coeruleus: subcellular localization in catecholaminergic dendrites, astrocytes, and presynaptic axon terminals. Brain Res. 795, 157–169. 10.1016/S0006-8993(98)00266-2 [DOI] [PubMed] [Google Scholar]
- Lei S., Deng P. Y., Porter J. E., Shin H. S. (2007). Adrenergic facilitation of GABAergic transmission in rat entorhinal cortex. J. Neurophysiol. 98, 2868–2877. 10.1152/jn.00679.2007 [DOI] [PubMed] [Google Scholar]
- Leo G., Guescini M., Genedani S., Stocchi V., Carone C., Filaferro M., et al. (2015). Acute isoproterenol induces anxiety-like behavior in rats and increases plasma content of extracellular vesicles. Physiol. Behav. 142, 79–84. 10.1016/j.physbeh.2015.02.002 [DOI] [PubMed] [Google Scholar]
- Lethbridge R. L., Walling S. G., Harley C. W. (2014). Modulation of the perforant path-evoked potential in dentate gyrus as a function of intrahippocampal β-adrenoceptor agonist concentration in urethane-anesthetized rat. Brain Behav. 4, 95–103. 10.1002/brb3.199 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li M., Yao W., Li S., Xi J. (2015). Norepinephrine induces the expression of interleukin-6 via β-adrenoreceptor-NAD(P)H oxidase system -NF-κB dependent signal pathway in U937 macrophages. Biochem. Biophys. Res. Commun. 460, 1029–1034. 10.1016/j.bbrc.2015.02.172 [DOI] [PubMed] [Google Scholar]
- Li S., Jin M., Zhang D., Yang T., Koeglsperger T., Fu H., et al. (2013). Environmental novelty activates β2-adrenergic signaling to prevent the impairment of hippocampal LTP by Aβ oligomers. Neuron 77, 929–941. 10.1016/j.neuron.2012.12.040 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lipina T. V., Fletcher P. J., Lee F. H., Wong A. H. C., Roder J. C. (2013). Disrupted-in-schizophrenia-1 Gln31Leu polymorphism results in social anhedonia associated with monoaminergic imbalance and reduction of CREB and β-arrestin-1,2 in the nucleus accumbens in a mouse model of depression. Neuropsychopharmacology 38, 423–436. 10.1038/npp.2012.197 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lippiello P., Hoxha E., Volpicelli F., Lo Duca G., Tempia F., Miniaci M. C. (2015). Noradrenergic modulation of the parallel fiber-Purkinje cell synapse in mouse cerebellum. Neuropharmacology 89, 33–42. 10.1016/j.neuropharm.2014.08.016 [DOI] [PubMed] [Google Scholar]
- Liu J.-F., Yang C., Deng J.-H., Yan W., Wang H.-M., Luo Y.-X., et al. (2015). Role of hippocampal β-adrenergic and glucocorticoid receptors in the novelty-induced enhancement of fear extinction. J. Neurosci. 35, 8308–8321. 10.1523/JNEUROSCI.0005-15.2015 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu W., Yuen E. Y., Allen P. B., Feng J., Greengard P., Yan Z. (2006). Adrenergic modulation of NMDA receptors in prefrontal cortex is differentially regulated by RGS proteins and spinophilin. Proc. Natl. Acad. Sci. U.S.A. 103, 18338–18343. 10.1073/pnas.0604560103 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu Y., Liang X., Ren W.-W., Li B.-M. (2014). Expression of β1- and β2-adrenoceptors in different subtypes of interneurons in the medial prefrontal cortex of mice. Neuroscience 257, 149–157. 10.1016/j.neuroscience.2013.10.078 [DOI] [PubMed] [Google Scholar]
- Loebel M., Grabowski P., Heidecke H., Bauer S., Hanitsch L. G., Wittke K., et al. (2016). Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome. Brain Behav. Immun. 52, 32–39. 10.1016/j.bbi.2015.09.013 [DOI] [PubMed] [Google Scholar]
- Luo F., Guo N.-N., Li S.-H., Tang H., Liu Y., Zhang Y. (2014a). Reduction of glutamate release probability and the number of releasable vesicles are required for suppression of glutamatergic transmission by β1-adrenoceptors in the medial prefrontal cortex. Neuropharmacology 83, 89–98. 10.1016/j.neuropharm.2014.03.020 [DOI] [PubMed] [Google Scholar]
- Luo F., Li S.-H., Tang H., Deng W.-K., Zhang Y., Liu Y. (2015a). Phenylephrine enhances glutamate release in the medial prefrontal cortex through interaction with N-type Ca2+ channels and release machinery. J. Neurochem. 132, 38–50. 10.1111/jnc.12941 [DOI] [PubMed] [Google Scholar]
- Luo F., Tang H., Cheng Z.-Y. (2015b). Stimulation of α1-adrenoceptors facilitates GABAergic transmission onto pyramidal neurons in the medial prefrontal cortex. Neuroscience 300, 63–74. 10.1016/j.neuroscience.2015.04.070 [DOI] [PubMed] [Google Scholar]
- Luo F., Tang H., Li B., Li S. (2014b). Activation of α1-adrenoceptors enhances excitatory synaptic transmission via a pre- and postsynaptic protein kinase C-dependent mechanism in the medial prefrontal cortex of rats. Eur. J. Neurosci. 39, 1281–1293. 10.1111/ejn.12495 [DOI] [PubMed] [Google Scholar]
- Maity S., Jarome T. J., Blair J., Lubin F. D., Nguyen P. V. (2016). Noradrenaline goes nuclear: epigenetic modifications during long-lasting synaptic potentiation triggered by activation of β-adrenergic receptors. J. Physiol. 594, 863–881. 10.1113/jp271432 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maity S., Rah S., Sonenberg N., Gkogkas C. G., Nguyen P. V. (2015). Norepinephrine triggers metaplasticity of LTP by increasing translation of specific mRNAs. Learn. Mem. 22, 499–508. 10.1101/lm.039222.115 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Manunta Y., Edeline J. M. (1997). Effects of noradrenaline on frequency tuning of rat auditory cortex neurons. Eur. J. Neurosci. 9, 833–847. 10.1111/j.1460-9568.1997.tb01433.x [DOI] [PubMed] [Google Scholar]
- Manunta Y., Edeline J. M. (2004). Noradrenergic induction of selective plasticity in the frequency tuning of auditory cortex neurons. J. Neurophysiol. 92, 1445–1463. 10.1152/jn.00079.2004 [DOI] [PubMed] [Google Scholar]
- Martins A. R. O., Froemke R. C. (2015). Coordinated forms of noradrenergic plasticity in the locus coeruleus and primary auditory cortex. Nat. Neurosci. 18, 1483–1492. 10.1038/nn.4090 [DOI] [PMC free article] [PubMed] [Google Scholar]
- McElligott Z. A., Winder D. G. (2008). Alpha1-adrenergic receptor-induced heterosynaptic long-term depression in the bed nucleus of the stria terminalis is disrupted in mouse models of affective disorders. Neuropsychopharmacology 33, 2313–2323. 10.1038/sj.npp.1301635 [DOI] [PMC free article] [PubMed] [Google Scholar]
- McKinney M., Jacksonville M. C. (2005). Brain cholinergic vulnerability: relevance to behavior and disease. Biochem. Pharmacol. 70, 1115–1124. 10.1016/j.bcp.2005.05.019 [DOI] [PubMed] [Google Scholar]
- Miller A. H., Haroon E., Raison C. L., Felger J. C. (2013). Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress. Anxiety 30, 297–306. 10.1002/da.22084 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mishima K., Tanoue A., Tsuda M., Hasebe N., Fukue Y., Egashira N., et al. (2004). Characteristics of behavioral abnormalities in alpha1d-adrenoceptors deficient mice. Behav. Brain Res. 152, 365–373. 10.1016/j.bbr.2003.10.038 [DOI] [PubMed] [Google Scholar]
- Nai Q., Dong H.-W., Hayar A., Linster C., Ennis M. (2009). Noradrenergic regulation of GABAergic inhibition of main olfactory bulb mitral cells varies as a function of concentration and receptor subtype. J. Neurophysiol. 101, 2472–2484. 10.1152/jn.91187.2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nakamura M., Suk K., Lee M.-G., Jang I.-S. (2013). α(2A) adrenoceptor-mediated presynaptic inhibition of GABAergic transmission in rat tuberomammillary nucleus neurons. J. Neurochem. 125, 832–842. 10.1111/jnc.12259 [DOI] [PubMed] [Google Scholar]
- Nalepa I., Kreiner G., Bielawski A., Rafa-Zabłocka K., Roman A. (2013). α1-Adrenergic receptor subtypes in the central nervous system: insights from genetically engineered mouse models. Pharmacol. Rep. 65, 1489–1497. 10.1016/s1734-1140(13)71509-3 [DOI] [PubMed] [Google Scholar]
- Nalepa I., Kreiner G., Kowalska M., Sanak M., Zelek-Molik A., Vetulani J. (2002). Repeated imipramine and electroconvulsive shock increase alpha 1A-adrenoceptor mRNA level in rat prefrontal cortex. Eur. J. Pharmacol. 444, 151–159. 10.1016/S0014-2999(02)01660-6 [DOI] [PubMed] [Google Scholar]
- Nicolaides N. C., Kyratzi E., Lamprokostopoulou A., Chrousos G. P., Charmandari E. (2015). Stress, the stress system and the role of glucocorticoids. Neuroimmunomodulation 22, 6–19. 10.1159/000362736 [DOI] [PubMed] [Google Scholar]
- Nikiforuk A. (2013). Quetiapine ameliorates stress-induced cognitive inflexibility in rats. Neuropharmacology 64, 357–364. 10.1016/j.neuropharm.2012.06.042 [DOI] [PubMed] [Google Scholar]
- O'Dell T. J., Connor S. A., Guglietta R., Nguyen P. V. (2015). β-Adrenergic receptor signaling and modulation of long-term potentiation in the mammalian hippocampus. Learn. Mem. 22, 461–471. 10.1101/lm.031088.113 [DOI] [PMC free article] [PubMed] [Google Scholar]
- O'Donnell J., Zeppenfeld D., McConnell E., Pena S., Nedergaard M. (2012). Norepinephrine: a neuromodulator that boosts the function of multiple cell types to optimize CNS performance. Neurochem. Res. 37, 2496–2512. 10.1007/s11064-012-0818-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ordway G. A., Schwartz M. A., Frazer A. (2007). Brain Norepinephrine. Cambridge: Cambridge University Press. [Google Scholar]
- Osaka T. (2009). Heat loss responses and blockade of prostaglandin E2-induced thermogenesis elicited by alpha1-adrenergic activation in the rostromedial preoptic area. Neuroscience 162, 1420–1428. 10.1016/j.neuroscience.2009.05.030 [DOI] [PubMed] [Google Scholar]
- Pankratov Y., Lalo U. (2015). Role for astroglial α1-adrenoreceptors in gliotransmission and control of synaptic plasticity in the neocortex. Front. Cell. Neurosci. 9:230. 10.3389/fncel.2015.00230 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paschalis A., Churchill L., Marina N., Kasymov V., Gourine A., Ackland G. (2009). beta1-Adrenoceptor distribution in the rat brain: an immunohistochemical study. Neurosci. Lett. 458, 84–88. 10.1016/j.neulet.2009.04.023 [DOI] [PubMed] [Google Scholar]
- Patel M., Joshi B. (2015). Modeling the evolving oscillatory dynamics of the rat locus coeruleus through early infancy. Brain Res. 1618, 181–193. 10.1016/j.brainres.2015.05.033 [DOI] [PubMed] [Google Scholar]
- Peet M., Yates R. A. (1981). Beta-blockers in the treatment of neurological and psychiatric disorders. J. Clin. Hosp. Pharm. 6, 155–171. 10.1111/j.1365-2710.1981.tb00988.x [DOI] [PubMed] [Google Scholar]
- Phillips C., Fahimi A., Das D., Mojabi F. S., Ponnusamy R., Salehi A. (2016). Noradrenergic system in down syndrome and Alzheimer's disease a target for therapy. Curr. Alzheimer Res. 13, 68–83. 10.2174/1567205012666150921095924 [DOI] [PubMed] [Google Scholar]
- Porterfield V. M., Gabella K. M., Simmons M. A., Johnson J. D. (2012). Repeated stressor exposure regionally enhances beta-adrenergic receptor-mediated brain IL-1β production. Brain Behav. Immun. 26, 1249–1255. 10.1016/j.bbi.2012.08.001 [DOI] [PubMed] [Google Scholar]
- Rajbhandari A. K., Baldo B. A., Bakshi V. P. (2015). Predator stress-induced CRF release causes enduring sensitization of basolateral amygdala norepinephrine systems that promote PTSD-like startle abnormalities. J. Neurosci. 35, 14270–14285. 10.1523/JNEUROSCI.5080-14.2015 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rajkowski J., Kubiak P., Aston-Jones G. (1994). Locus coeruleus activity in monkey: phasic and tonic changes are associated with altered vigilance. Brain Res. Bull. 35, 607–616. 10.1016/0361-9230(94)90175-9 [DOI] [PubMed] [Google Scholar]
- Ramakrishna D., Subhash M. N. (2012). Effect of amitriptyline on adrenergic receptor number and second messenger function in rat brain. Pakistan J. Biol. Sci. 15, 871–876. 10.3923/pjbs.2012.871.876 [DOI] [PubMed] [Google Scholar]
- Ramos B. P., Arnsten A. F. (2007). Adrenergic pharmacology and cognition: focus on the prefrontal cortex. Pharmacol. Ther. 113, 523–536. 10.1016/j.pharmthera.2006.11.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rash J. E., Olson C. O., Davidson K. G. V., Yasumura T., Kamasawa N., Nagy J. I. (2007). Identification of connexin36 in gap junctions between neurons in rodent locus coeruleus. Neuroscience 147, 938–956. 10.1016/j.neuroscience.2007.04.061 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rauggi R., Cassanelli A., Raone A., Tagliamonte A., Gambarana C. (2005). Study of mirtazapine antidepressant effects in rats. Int. J. Neuropsychopharmacol. 8, 369–379. 10.1017/S1461145705005146 [DOI] [PubMed] [Google Scholar]
- Reiche E. M. V., Nunes S. O. V., Morimoto H. K. (2004). Stress, depression, the immune system, and cancer. Lancet Oncol. 5, 617–625. 10.1016/S1470-2045(04)01597-9 [DOI] [PubMed] [Google Scholar]
- Robbins T. W., Arnsten A. F. T. (2009). The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu. Rev. Neurosci. 32, 267–287. 10.1146/annurev.neuro.051508.135535 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robinson A. M., Buttolph T., Green J. T., Bucci D. J. (2015). Physical exercise affects attentional orienting behavior through noradrenergic mechanisms. Behav. Neurosci. 129, 361–367. 10.1037/bne0000054 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roszkowski M., Manuella F., von Ziegler L., Durán-Pacheco G., Moreau J.-L., Mansuy I. M., et al. (2016). Rapid stress-induced transcriptomic changes in the brain depend on beta-adrenergic signaling. Neuropharmacology 107, 329–338. 10.1016/j.neuropharm.2016.03.046 [DOI] [PubMed] [Google Scholar]
- Roychowdhury S., Pena-Contreras Z., Tam J., Yadlapalli A., Dinh L., Nichols J. A., et al. (2012). alpha(2)- and beta-adrenoceptors involvement in nortriptyline modulation of auditory sustained attention and impulsivity. Psychopharmacol. 222, 237–245. 10.1007/s00213-012-2635-y [DOI] [PubMed] [Google Scholar]
- Roychowdhury S., Zwierzchowski A. N., Garcia-Oscos F., Olguin R. C., Delgado R. S., Atzori M. (2014). Layer- and area-specificity of the adrenergic modulation of synaptic transmission in the rat neocortex. Neurochem. Res. 39, 2377–2384. 10.1007/s11064-014-1440-x [DOI] [PubMed] [Google Scholar]
- Rozas C., Carvallo C., Contreras D., Carreño M., Ugarte G., Delgado R., et al. (2015). Methylphenidate amplifies long-term potentiation in rat hippocampus CA1 area involving the insertion of AMPA receptors by activation of β-adrenergic and D1/D5 receptors. Neuropharmacology 99, 15–27. 10.1016/j.neuropharm.2015.07.003 [DOI] [PubMed] [Google Scholar]
- Ryan K. J., Griffin É., Yssel J. D., Ryan K. M., McNamee E. N., Harkin A., et al. (2013). Stimulation of central β2-adrenoceptors suppresses NFκB activity in rat brain: a role for IκB. Neurochem. Int. 63, 368–378. 10.1016/j.neuint.2013.07.006 [DOI] [PubMed] [Google Scholar]
- Sakata T., Yoshimatsu H., Kurokawa M. (1997). Hypothalamic neuronal histamine: implications of its homeostatic control of energy metabolism. Nutrition 13, 403–411. 10.1016/S0899-9007(97)91277-6 [DOI] [PubMed] [Google Scholar]
- Salgado H., Garcia-Oscos F., Martinolich L., Hall S., Restom R., Tseng K. Y., et al. (2012a). Pre- and postsynaptic effects of norepinephrine on gamma-aminobutyric acid-mediated synaptic transmission in layer 2/3 of the rat auditory cortex. Synapse 66, 20–28. 10.1002/syn.20979 [DOI] [PubMed] [Google Scholar]
- Salgado H., Garcia-Oscos F., Patel A., Martinolich L., Nichols J. A., Dinh L., et al. (2011). Layer-specific noradrenergic modulation of inhibition in cortical layer II/III. Cereb. Cortex 21, 212–221. 10.1093/cercor/bhq081 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Salgado H., Kohr G., Trevino M. (2012b). Noradrenergic “tone” determines dichotomous control of cortical spike-timing-dependent plasticity. Sci. Rep. 2, 163–176. 10.1038/srep00417 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Salgado H., Treviño M., Atzori M. (2016). Layer- and area-specific actions of norepinephrine on cortical synaptic transmission. Brain Res. 1641, 163–176. 10.1016/j.brainres.2016.01.033 [DOI] [PubMed] [Google Scholar]
- Santulli G., Iaccarino G. (2013). Pinpointing beta adrenergic receptor in ageing pathophysiology: victim or executioner? Evidence from crime scenes. Immun. Ageing, 10, 10. 10.1186/1742-4933-10-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sapolsky R. M. (2015). Stress and the brain: individual variability and the inverted-U. Nat. Neurosci. 18, 1344–1346. 10.1038/nn.4109 [DOI] [PubMed] [Google Scholar]
- Schmeichel B. E., Berridge C. W. (2013). Wake-promoting actions of noradrenergic α1 - and β-receptors within the lateral hypothalamic area. Eur. J. Neurosci. 37, 891–900. 10.1111/ejn.12084 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sekio M., Seki K. (2015). Lipopolysaccharide-induced depressive-like behavior is associated with α1-adrenoceptor dependent downregulation of the membrane GluR1 subunit in the mouse medial prefrontal cortex and ventral tegmental area. Int. J. Neuropsychopharmacol. 18:pyu005. 10.1093/ijnp/pyu005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sessler F. M., Liu W., Kirifides M. L., Mouradian R. D., Lin R. C., Waterhouse B. D. (1995). Noradrenergic enhancement of GABA-induced input resistance changes in layer V regular spiking pyramidal neurons of rat somatosensory cortex. Brain Res. 675, 171–182. 10.1016/0006-8993(95)00060-4 [DOI] [PubMed] [Google Scholar]
- Shakhawat A. M. D., Gheidi A., MacIntyre I. T., Walsh M. L., Harley C. W., Yuan Q. (2015). Arc-expressing neuronal ensembles supporting pattern separation require adrenergic activity in anterior piriform cortex: an exploration of neural constraints on learning. J. Neurosci. 35, 14070–14075. 10.1523/jneurosci.2690-15.2015 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shan L., Bao A.-M., Swaab D. F. (2015). The human histaminergic system in neuropsychiatric disorders. Trends Neurosci. 38, 167–177. 10.1016/j.tins.2014.12.008 [DOI] [PubMed] [Google Scholar]
- Sherpa A. D., Xiao F., Joseph N., Aoki C., Hrabetova S. (2016). Activation of β-adrenergic receptors in rat visual cortex expands astrocytic processes and reduces extracellular space volume. Synapse 70, 307–316. 10.1002/syn.21908 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Silvani A., Calandra-Buonaura G., Dampney R. A. L., Cortelli P. (2016). Brain-heart interactions: physiology and clinical implications. Philos. Trans. A Math. Phys. Eng. Sci. 374:20150181. 10.1098/rsta.2015.0181 [DOI] [PubMed] [Google Scholar]
- Simpson K. L., Lin R. C. (2007). Neuroanatomical and chemical organization of the Locus cerouleus, in Brain Norepinephrine, eds Ordway G. A., Schwarts M. A., Frazer A. (New York, NY: Cambridge University Press; ), 9–52. [Google Scholar]
- Siuda E. R., McCall J. G., Al-Hasani R., Shin G., Il Park S., Schmidt M. J., et al. (2015). Optodynamic simulation of β-adrenergic receptor signalling. Nat. Commun. 6, 8480. 10.1038/ncomms9480 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smythies J. (2005a). Section I. The cholinergic system. Int. Rev. Neurobiol. 64, 1–122. 10.1016/S0074-7742(05)64001-9 [DOI] [PubMed] [Google Scholar]
- Smythies J. (2005b). Section V. Serotonin system. Int. Rev. Neurobiol. 64, 217–268. 10.1016/S0074-7742(05)64005-6 [DOI] [PubMed] [Google Scholar]
- Sofuoglu M., Sewell R. A. (2009). Norepinephrine and stimulant addiction. Addict. Biol. 14, 119–129. 10.1111/j.1369-1600.2008.00138.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- Somkuwar S. S., Kantak K. M., Dwoskin L. P. (2015). Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder. J. Neurosci. Methods 252, 55–63. 10.1016/j.jneumeth.2015.02.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Song D., Xu J., Hertz L., Peng L. (2015). Regulatory volume increase in astrocytes exposed to hypertonic medium requires β1 -adrenergic Na(+)/K(+) -ATPase stimulation and glycogenolysis. J. Neurosci. Res. 93, 130–139. 10.1002/jnr.23469 [DOI] [PubMed] [Google Scholar]
- Spreng M., Cotecchia S., Schenk F. (2001). A behavioral study of alpha-1b adrenergic receptor knockout mice: increased reaction to novelty and selectively reduced learning capacities. Neurobiol. Learn. Mem. 75, 214–229. 10.1006/nlme.2000.3965 [DOI] [PubMed] [Google Scholar]
- Steenbergen L., Sellaro R., de Rover M., Hommel B., Colzato L. S. (2015). No role of beta receptors in cognitive flexibility: evidence from a task-switching paradigm in a randomized controlled trial. Neuroscience 295, 237–242. 10.1016/j.neuroscience.2015.03.049 [DOI] [PubMed] [Google Scholar]
- Stemmelin J., Cohen C., Terranova J.-P., Lopez-Grancha M., Pichat P., Bergis O., et al. (2008). Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders. Neuropsychopharmacology 33, 574–587. 10.1038/sj.npp.1301424 [DOI] [PubMed] [Google Scholar]
- Sterley T.-L., Howells F. M., Russell V. A. (2016). Genetically determined differences in noradrenergic function: The spontaneously hypertensive rat model. Brain Res. 1641, 291–305. 10.1016/j.brainres.2015.11.019 [DOI] [PubMed] [Google Scholar]
- Stone E. A., Quartermain D. (1999). Alpha-1-noradrenergic neurotransmission, corticosterone, and behavioral depression. Biol. Psychiatry 46, 1287–1300. 10.1016/S0006-3223(99)00234-6 [DOI] [PubMed] [Google Scholar]
- Szot P., Lester M., Laughlin M. L., Palmiter R. D., Liles L. C., Weinshenker D. (2004). The anticonvulsant and proconvulsant effects of alpha2-adrenoreceptor agonists are mediated by distinct populations of alpha2A-adrenoreceptors. Neuroscience 126, 795–803. 10.1016/j.neuroscience.2004.04.030 [DOI] [PubMed] [Google Scholar]
- Tamburella A., Micale V., Leggio G. M., Drago F. (2010). The beta3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changes. Eur. Neuropsychopharmacol. 20, 704–713. 10.1016/j.euroneuro.2010.04.006 [DOI] [PubMed] [Google Scholar]
- Terakado M. (2014). Adrenergic regulation of GABA release from presynaptic terminals in rat cerebral cortex. J. Oral Sci. 56, 49–57. 10.2334/josnusd.56.49 [DOI] [PubMed] [Google Scholar]
- Tohyama M., Maeda T., Hashimoto J., Shrestha G. R., Tamura O. (1974). Comparative anatomy of the locus coeruleus. I. Organization and ascending projections of the catecholamine containing neurons in the pontine region of the bird, Melopsittacus undulatus. J. Hirnforsch. 15, 319–330. [PubMed] [Google Scholar]
- Ursino M. G., Vasina V., Raschi E., Crema F., De Ponti F. (2009). The beta3-adrenoceptor as a therapeutic target: current perspectives. Pharmacol. Res. 59, 221–234. 10.1016/j.phrs.2009.01.002 [DOI] [PubMed] [Google Scholar]
- Usher M., Cohen J. D., Servan-Schreiber D., Rajkowski J., Aston-Jones G. (1999). The role of locus coeruleus in the regulation of cognitive performance. Science 283, 549–554. 10.1126/science.283.5401.549 [DOI] [PubMed] [Google Scholar]
- van Tol M.-J., van der Wee N. J. A., van den Heuvel O. A., Nielen M. M. A., Demenescu L. R., Aleman A., et al. (2010). Regional brain volume in depression and anxiety disorders. Arch. Gen. Psychiatry 67, 1002–1011. 10.1001/archgenpsychiatry.2010.121 [DOI] [PubMed] [Google Scholar]
- Velásquez-Martínez M. C., Vázquez-Torres R., Rojas L. V., Sanabria P., Jiménez-Rivera C. A. (2015). Alpha-1 adrenoreceptors modulate GABA release onto ventral tegmental area dopamine neurons. Neuropharmacology 88, 110–121. 10.1016/j.neuropharm.2014.09.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Verheij M. M. M., Saigusa T., Koshikawa N., Cools A. R. (2015). Accumbal α-adrenoceptors, but not β-adrenoceptors, regulate behaviour that is mediated by reserpine-sensitive storage vesicles. Behav. Pharmacol. 26, 81–90. 10.1097/FBP.0000000000000098 [DOI] [PubMed] [Google Scholar]
- Viemari J.-C., Garcia A. J., Doi A., Elsen G., Ramirez J.-M. (2013). β-Noradrenergic receptor activation specifically modulates the generation of sighs in vivo and in vitro. Front. Neural Circuits 7:179. 10.3389/fncir.2013.00179 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Villégier A.-S., Drouin C., Bizot J.-C., Marien M., Glowinski J., Colpaërt F., et al. (2003). Stimulation of postsynaptic alpha1b- and alpha2-adrenergic receptors amplifies dopamine-mediated locomotor activity in both rats and mice. Synapse 50, 277–284. 10.1002/syn.10267 [DOI] [PubMed] [Google Scholar]
- Volk N., Paul E. D., Haramati S., Eitan C., Fields B. K. K., Zwang R., et al. (2014). MicroRNA-19b associates with Ago2 in the amygdala following chronic stress and regulates the adrenergic receptor beta 1. J. Neurosci. 34, 15070–15082. 10.1523/JNEUROSCI.0855-14.2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wada H., Inagaki N., Yamatodani A., Watanabe T. (1991). Is the histaminergic neuron system a regulatory center for whole-brain activity? Trends Neurosci. 14, 415–418. 10.1016/0166-2236(91)90034-R [DOI] [PubMed] [Google Scholar]
- Wahlbeck K., Cheine M. V., Gilbody S., Ahonen J. (2000). Efficacy of beta-blocker supplementation for schizophrenia: a systematic review of randomized trials. Schizophr. Res. 41, 341–347. 10.1016/S0920-9964(99)00069-9 [DOI] [PubMed] [Google Scholar]
- Wanaka A., Kiyama H., Murakami T., Matsumoto M., Kamada T., Malbon C. C., et al. (1989). Immunocytochemical localization of beta-adrenergic receptors in the rat brain. Brain Res. 485, 125–140. 10.1016/0006-8993(89)90674-4 [DOI] [PubMed] [Google Scholar]
- Wang D., Fu Q., Zhou Y., Xu B., Shi Q., Igwe B., et al. (2013). β2 adrenergic receptor, protein kinase A (PKA) and c-Jun N-terminal kinase (JNK) signaling pathways mediate tau pathology in Alzheimer disease models. J. Biol. Chem. 288, 10298–10307. 10.1074/jbc.M112.415141 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang M., Gamo N. J., Yang Y., Jin L. E., Wang X.-J., Laubach M., et al. (2011). Neuronal basis of age-related working memory decline. Nature 476, 210–213. 10.1038/nature10243 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang Y., Zhang Q. J., Liu J., Ali U., Gui Z. H., Hui Y. P., et al. (2010). Noradrenergic lesion of the locus coeruleus increases the firing activity of the medial prefrontal cortex pyramidal neurons and the role of alpha2-adrenoceptors in normal and medial forebrain bundle lesioned rats. Brain Res. 1324, 64–74. 10.1016/j.brainres.2010.02.009 [DOI] [PubMed] [Google Scholar]
- Waselus M., Valentino R. J., Van Bockstaele E. J. (2011). Collateralized dorsal raphe nucleus projections: a mechanism for the integration of diverse functions during stress. J. Chem. Neuroanat. 41, 266–280. 10.1016/j.jchemneu.2011.05.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Waterhouse B. D., Sessler F. M., Liu W., Lin C. S. (1991). Second messenger-mediated actions of norepinephrine on target neurons in central circuits: a new perspective on intracellular mechanisms and functional consequences. Prog. Brain Res. 88, 351–362. 10.1016/s0079-6123(08)63822-4 [DOI] [PubMed] [Google Scholar]
- Weinshenker D., Schroeder J. P. (2007). There and back again: a tale of norepinephrine and drug addiction. Neuropsychopharmacology 32, 1433–1451. 10.1038/sj.npp.1301263 [DOI] [PubMed] [Google Scholar]
- Wenzel J. M., Cotten S. W., Dominguez H. M., Lane J. E., Shelton K., Su Z.-I., et al. (2014). Noradrenergic β-receptor antagonism within the central nucleus of the amygdala or bed nucleus of the stria terminalis attenuates the negative/anxiogenic effects of cocaine. J. Neurosci. 34, 3467–3474. 10.1523/JNEUROSCI.3861-13.2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilson M. A., McNaughton B. L. (1994). Reactivation of hippocampal ensemble memories during sleep. Science 265, 676–679. 10.1126/science.8036517 [DOI] [PubMed] [Google Scholar]
- Wohleb E. S., Hanke M. L., Corona A. W., Powell N. D., Stiner L. M., Bailey M. T., et al. (2011). β-Adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat. J. Neurosci. 31, 6277–6288. 10.1523/JNEUROSCI.0450-11.2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yang L. J., Liu X., Liu D. X., Jiang H., Mao X. Q., Wang C., et al. (2012). Effects of different adrenergic blockades on the stress resistance of Wistar rats. Neurosci. Lett. 511, 95–100. 10.1016/j.neulet.2012.01.046 [DOI] [PubMed] [Google Scholar]
- Yuen E. Y., Qin L., Wei J., Liu W., Liu A., Yan Z. (2014). Synergistic regulation of glutamatergic transmission by serotonin and norepinephrine reuptake inhibitors in prefrontal cortical neurons. J. Biol. Chem. 289, 25177–25185. 10.1074/jbc.M114.567610 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang L., Ouyang M., Ganellin C. R., Thomas S. A. (2013). The slow afterhyperpolarization: a target of β1-adrenergic signaling in hippocampus-dependent memory retrieval. J. Neurosci. 33, 5006–5016. 10.1523/JNEUROSCI.3834-12.2013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang Z., Cordeiro Matos S., Jego S., Adamantidis A., Séguéla P. (2013). Norepinephrine drives persistent activity in prefrontal cortex via synergistic α1 and α2 adrenoceptors. PLoS ONE 8:e66122. 10.1371/journal.pone.0066122 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhou H.-C., Sun Y.-Y., Cai W., He X.-T., Yi F., Li B.-M., et al. (2013). Activation of β2-adrenoceptor enhances synaptic potentiation and behavioral memory via cAMP-PKA signaling in the medial prefrontal cortex of rats. Learn. Mem. 20, 274–284. 10.1101/lm.030411.113 [DOI] [PubMed] [Google Scholar]
- Zhou J., Luo Y., Zhang J.-T., Li M.-X., Wang C.-M., Guan X.-L., et al. (2015). Propranolol decreases retention of fear memory by modulating the stability of surface glutamate receptor GluA1 subunits in the lateral amygdala. Br. J. Pharmacol. 172, 5068–5082. 10.1111/bph.13272 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhou L., Williams T., Lachey J. L., Kishi T., Cowley M. A., Heisler L. K. (2005). Serotonergic pathways converge upon central melanocortin systems to regulate energy balance. Peptides 26, 1728–1732. 10.1016/j.peptides.2004.12.028 [DOI] [PubMed] [Google Scholar]
- Zimnik N. C., Treadway T., Smith R. S., Araneda R. C. (2013). α(1A)-Adrenergic regulation of inhibition in the olfactory bulb. J. Physiol. 591, 1631–1643. 10.1113/jphysiol.2012.248591 [DOI] [PMC free article] [PubMed] [Google Scholar]